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ABSTRACT
BETA-CAROTENE IN THE BOVINE CORPUS LUTEUM
by
Stephen G Judd 
University o f New Hampshire, May, 1997
There have been conflicting reports which associate a low dietary intake or plasma 
concentration o f beta-carotene (BC) with decreased fertility in dairy cows. The bovine 
corpus luteum (CL), a transient endocrine gland formed subsequent to ovulation, produces 
the steroid hormone progesterone which sustains pregnancy and is associated with 
fertility Because o f its high concentrations o f the antioxidant nutrient beta-carotene, the 
CL was examined to identify an in vivo function for BC, other than that as a precursor o f 
retinol. Five non-lactating Jersey cows were fed a basal ration containing a low BC 
concentration. Each cow received either 0, 1.6, 8.0, 16.0, or 80.0 mg/day o f supplemental 
BC in the form o f water-soluble beadlets incorporated into grain. Changes in plasma BC 
were measured weekly. After each of four feeding periods (7 weeks each), a mid-cycle 
CL (9-11 days following estrus) and plasma were harvested from each cow. Plasma and 
CL beta-carotene concentrations were directly related to the dietary BC level and, while 
on the BC deficient diet were similar to those seen in humans. Western immunoblotting 
was used to identify the steroidogenic enzymes adrenodoxin (Adx, -14 kDa) and 
cholesterol side-chain cleavage cytochrome P-450 (P450scc, 49 kDa). The enzymes Adx 
and P-450scc catalyze the first and rate-limiting reaction in progesterone synthesis.
vii
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Antisera specific for Adx or P450scc, in addition to recognizing their respective proteins, 
recognized a protein o f higher molecular weight (63 kDa). The 63 kDa protein band, 
believed to be P450scc and Adx chemically cross-linked in a one to one ratio, was present 
consistently in the lanes where CL beta-carotene concentrations were below ~ 11 nmol/g. 
On the other hand, the cross-linked protein was not apparent in lanes where the CL beta- 
carotene concentrations were above -50 nmol/g. In lanes where the CL beta-carotene 
concentrations were between 11 and 50 nmol/g, the cross-linked protein was sometimes 
apparent, but not consistently. Thus, it appears that BC protects the mitochondrial 
enzymes Adx and P450scc against damage from free radicals produced during 
steroidogenesis. These observations may help explain studies which show that antioxidant 
vitamins enhance steroid production.
viii
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INTRODUCTION
In 1981, it was suggested that carotenoids, such as beta-carotene, may be 
protective against cancer (1). Since that time, many epidemiological surveys have been 
conducted to determine the relationship between dietary carotenoids and various 
diseases, including numerous cancers, heart disease, and macular degeneration. While 
there is an emerging consensus that consuming fruits and vegetables which are 
carotenoid-rich reduces the incidence of many chronic diseases, the beneficial effects of 
individual carotenoids remain in dispute. One reason for this, is that the mechanism of 
action whereby carotenoids might affect these diseases is unknown. Much of the 
research in this area has focused on one carotenoid, beta-carotene.
The structural characteristics o f beta-carotene, its similarity to other 
carotenoids, and its relationship with Vitamin A compound the difficulties of 
identifying its critical functions. Beta-carotene imparts a yellow to orange color to 
those plants or tissues which contain it, though this color is often masked by the green 
of chlorophyll with which it colocalizes in photosynthetic tissue. When consumed by 
animals, beta-carotene may be utilized by the body to produce Vitamin A. In addition 
to this provitamin A function, beta-carotene may also act as an antioxidant, protecting 
the lipid with which it becomes associated from the damage o f oxidants.
In addition to its relationship to chronic disease in humans, beta-carotene has 
been reported to affect fertility in cows. While field-based studies have shown
1
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conflicting results, some suggest that feeding supplementary beta-carotene may enhance 
fertility, depending upon the beta-carotene status o f the control group. However, as 
with human diseases, no mechanism of action for the relationship between beta- 
carotene and fertility has been elucidated.
One tissue which contains beta-carotene and also plays a role in fertility is the 
corpus luteum. The bovine corpus luteum, a metabolically active steroidogenic gland 
which is formed in the ovary of cows subsequent to ovulation, derives its name, 
“ yellow body” , from its coloration which is a result o f its high beta-carotene 
concentration. After ovulation, the corpus luteum forms from the cells o f the follicle 
and secretes the steroid progesterone. The high levels o f circulating progesterone 
sustained by the corpus luteum, prepare the endometrium of the uterus for implantation 
of an embryo and help maintain pregnancy if  successful implantation occurs. I f  the 
ovum is not fertilized, the corpus luteum undergoes regression, resulting in its 
functional and structural demise. A new corpus luteum is formed following each 
ovulation.
In addition to its possible implications for fertility, the bovine corpus luteum is 
an excellent model in which to examine beta-carotene metabolism and function because 
of its high concentration o f beta-carotene, its high metabolic activity, and availability of 
the tissue. Since the corpus luteum is formed anew each estrous cycle, its beta- 
carotene concentration reflects changes in serum beta-carotene concentrations, and it 
does not retain a "memory" o f past beta-carotene exposure. Additionally, the corpus 
luteum can be removed from the cow without harm to the ovary and without anesthesia
2
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
in a simple surgical procedure. This allows for the harvest o f multiple corpora lutea 
over time from the same cow exposed to different dietary treatments.
The research described in this dissertation was undertaken in an attempt to 
characterize the accumulation, localization, and function o f beta-carotene within the 
bovine corpus luteum. The goal was not only to elucidate a function o f beta-carotene 
in the corpus luteum, but to establish a model in which beta-carotene metabolism 
within a tissue can be examined. The hypothesis being tested was that dietary beta- 
carotene affects plasma and corpus luteum beta-carotene concentrations and that high 
levels o f corpus luteum beta-carotene inhibit cross-linking of steroidogenic enzymes. 
Specific Aims:
1. Determine the relationship between dietary, plasma, lipoprotein, and corpus luteum 
concentrations of beta-carotene, and the variability in this relationship between 
cows.
2. Determine the subcellular distribution of beta-carotene within the bovine corpus 
luteum.
3. Determine the relationship between dietary, plasma, lipoprotein, or corpus luteum 
concentrations o f beta-carotene and plasma progesterone concentration in the cow.
4. Determine the effect o f varying dietary beta-carotene levels on the steroidogenic 
enzymes o f the corpus luteum.
3
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CHAPTER I
REVIEW OF THE LITERATURE 
Beta-carotene
Structure and Function
Carotenoids are a class o f hydrocarbons which are derived from lycopene (T ,T  
-carotene), an acyclic C4oHS6 structure which has a central chain o f conjugated double 
bonds and is formed by the condensation o f isoprenoid subunits. The carotenoids are a 
diverse family o f pigments which give rise to many o f the yellow, orange and red 
colorations found in nature, though this coloration is masked by the intense green of 
chlorophyll in active photosynthetic tissue. While more than 600 carotenoids have been 
identified in nature (2 ), much o f the research in this field has focused on beta-carotene 
(BC, Figure I)  since it was first isolated from carrots by Wackenroder in 1831. Beta- 
carotene is a carotenoid derived from lycopene by cyclization at each end of the 
molecule, a process thought to occur only in bacteria, algae, plants, and fungi.
4
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Figure I  Metabolic pathways of beta-carotene. Beta-carotene may undergo 
central cleavage to yield retinal, which may then be converted to the active 
metabolites retinol or retinoic acid. Alternatively, beta-carotene may be 
cleaved at a non-central site (excentric cleavage) to yield a beta-apo-carotenal 
which can be subsequently converted to retinoic acid or retinol.
5
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It has been proposed, by Olson (3), that carotenoids’ biological effects in 
nature can be broken down into three categories: functions, actions and associations. 
Krinsky (4) grouped these effects o f carotenoids as follows:
1. Functions: accessory pigments in photosynthesis, via singlet excited 
carotenoid; protection against photosensitization, via triplet excited carotenoid: 
provitamin A, via central and excentric cleavage.
2. Actions: antioxidant; immunoenhancement; inhibition o f mutagenesis and 
transformation; inhibition o f premalignant lesions; screening pigment in 
primate fovea.
3. Associations: decreased risk o f macular degeneration and cataracts; 
decreased risk o f some cancers; decreased risk o f some cardiovascular events; 
nonphotochemical fluorescence quenching.
Functions are those effects o f carotenoids which are "essential to the normal well-being 
o f the organism in question." (3) In photosynthetic membranes, carotenoids perform 
two functions: 1) they collect light for photosynthesis and 2 ) protect the photosynthetic 
apparatus from the destructive effects o f light and oxygen (5). Because of their 
chemical structures, carotenoids absorb light, with the maximal absorption being of 
blue-green light (~450 nm), however, most chlorophylls do not absorb blue-green 
light or are poor absorbers. In photosynthetic tissues, carotenoids absorb blue-green 
light and then transfer the resultant energy to chlorophyll, with which they are in a 
highly ordered relationship within their apoproteins, for photosynthesis. In addition to 
this role of transferring energy to chlorophyll, carotenoids also serve a protective 
function by accepting energy from chlorophyll. Under intense light conditions, 
chlorophyll can be excited into a triplet state which, i f  the energy is dissipated in an 
uncontrolled fashion, can lead to cellular damage. Carotenoids accept this excess 
energy from chlorophyll and dissipate it thermally, preventing damage to the organism. 
The energy from triplet state chlorophyll can also be transferred to oxygen yielding
6
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singlet oxygen, which can also cause cellular damage. Carotenoids quench singlet 
oxygen, thereby protecting the organism.
Beta-carotene is one of the carotenoids which can be converted to retinol 
(Vitamin A), and therefore possesses what are known as provitamin A properties 
{Figure I). This activity is considered a function because provitamin A carotenoids are 
able to alleviate the deficiency symptoms of animals on vitamin A-deficient diets. As a 
precursor to vitamin A, BC is cleaved in the intestinal mucosa by beta-carotene 15-15'- 
dioxygenase (EC 1.13.11.21) to retinal and then reduced by retinal reductase (EC 
1.1.1.71) to form retinol. Beta-carotene, obtained from the diet, is the most 
nutritionally active carotenoid and accounts for 15-30% of total serum carotenoids in 
humans (6 ). The efficiency of this conversion, currently accepted to be 6:1 (BC to 
retinol on a weight-for-weight basis), and its impact on human nutriture has been 
reviewed (7). This 6:1 conversion efficiency is based on the assumptions that 
carotenoids are absorbed one half as well as retinol, and the average extent of 
conversion is 33%. However, these assumptions remain in question, and the extent to 
which dietary BC can substitute for preformed vitamin A is still being studied.
Retinol, preformed from dietary sources or formed in the intestinal mucosa 
from BC , is subsequently esterified, transported via chylomicrons through the lymph 
to the general circulation, and chylomicron remnants are formed in the capillaries. 
These chylomicron remnants are cleared primarily by the liver, and retinyl esters are 
stored or used as needed (8 ). Other tissues may also clear chylomicron remnants to 
some extent. Stored retinol may be released from the liver and delivered to target 
tissues bound to retinol binding protein and subsequently transported to active sites by
7
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cell specific binding proteins. The functions o f retinol in the body can be divided into 
visual and non-visual functions. In vision, retinol and its metabolites serve a vital role 
in the signal transduction process (9). The 11-cis-isomer o f retinaldehyde, attached to 
opsin in rhodopsin, is isomerized to its all-trans configuration by light. This event 
triggers the nerve impulse to the brain which forms the perception o f light. All-trans- 
retinaldehyde is released from the opsin and reduced to all-trans-retinol. In the dark, 
this is isomerized to 1 1-cis-retinol and oxidized to 11-cis-retinaldehyde, which 
recombines with opsin to re-form rhodopsin, completing the visual cycle. Deficiency 
of vitamin A reduces the available pool o f retinol in the eye, and leads to night 
blindness, a classical vitamin A deficiency symptom. The non-visual functions of 
retinol include the maintenance of normal epithelial cell differentiation, normal bone 
growth, spermatogenesis, and embryonic development (9) .
The majority o f the non-visual effects o f retinoids are thought to be modulated 
by retinoic acid ( 10), however, it has been suggested that retinoic acid cannot substitute 
for all effects o f retinol in growth regulation, and that other retinol metabolites may act 
as mediators. Retinoic acid exerts its effects through the regulation o f gene transcrip­
tion via retinoic acid nuclear receptors, which are members of the steroid hormone re­
ceptor superfamily (11). Retinoic acid is formed within target cells from retinol bound 
to cellular retinol-binding protein by cytosolic and microsomal retinol dehydrogenases 
(12,13). Additionally, retinoic acid can be formed directly from BC via, what is 
called, excentric cleavage (14). Excentric cleavage describes a process in which, rather 
than being cleaved centrally and producing two molecules of retinal, BC is cleaved 
nonspecifically at one of its non-central double bonds (Figure I). This cleavage results
8
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in the formation of beta-apocarotenals o f various chain lengths, all o f which can be 
converted either to retinal or oxidized to the corresponding beta-apocarotenoic acids, 
which may undergo a form o f beta-oxidation to yield retinoic acid. The ability to 
convert BC to retinoic acid has been shown in intestinal mucosa, liver, kidney, lung, 
and testes (15). Thus, BC serves as a precursor to both retinol and directly for its 
active metabolite retinoic acid.
Carotenoids’ actions have been described as physiological or pharmacological 
responses to the administration o f carotenoids (3) and may be related to the intact 
carotenoid molecule, as opposed to a metabolite. The antioxidant actions o f BC are 
due to its extended system o f conjugated double bonds (see Figure 1). While the exact 
mechanism o f beta-carotene/radical reactions is not clear, it is hypothesized that beta- 
carotene may react directly with a peroxyl radical to form a resonance-stabilized radical 
(16). This is supported by the fact that most o f the products o f the interaction of beta- 
carotene and radicals are carbonyl derivatives o f beta-carotene (17). In plants, where 
BC and other carotenoids are found in close association with chlorophyll, BC protects 
the chloroplast from singlet oxygen, a free-radical produced during conditions of high 
light intensity (2 ).
The ability of BC to act as an antioxidant in vitro has been shown by Jialal et al. 
(18), who demonstrated that beta-carotene inhibits the oxidation o f isolated low density 
lipoprotein (LDL); the oxidative modification of LDL is believed to be the necessary 
first-step in the development o f atherosclerosis (19).
In vivo inhibition o f oxidation has also been demonstrated. Allard and 
colleagues (20) have shown that supplementation of smokers with 20 mg/day BC for
9
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four weeks significantly reduced breath-pentane output (BPO), a measure o f in vivo 
lipid peroxidation. No effect on BPO was seen in non-smokers, though they showed 
similar increases in serum BC concentration. It is not clear whether this measure of 
lipid peroxidation has any significance for the health o f the subjects, or where the effect 
of BC is exerted.
The cellular transformation inhibiting effects o f provitamin A and non­
provitamin A carotenoids have also been demonstrated in vitro (21,22). Bertram et al. 
(23) showed that treatment of a murine fibroblast cell-line with either BC or 
canthaxanthin, a non-provitamin A carotenoid, inhibited the 3-methylcholanthrene- 
induced transformation o f the cells. Since both a provitamin A and non-provitamin A 
carotenoid exerted the same effect, they concluded that this transformation inhibiting 
effect may be due to their lipid antioxidant properties. This same group subsequently 
showed that this inhibition was independent o f the carotenoids’ antioxidant status, but 
was due to the carotenoids’ ability to up-regulate expression of the Connexin43 gene 
which encodes for a major gap junctional protein (24). Schwartz and colleagues (25) 
demonstrated that BC. when added to cultured cells, inhibits human epidermal 
carcinoma cell proliferation, but not normal keratinocyte proliferation. This inhibition 
was associated with the appearance of a unique heat-shock protein, presumably induced 
by the BC. Thus, it appears that carotenoids may have the ability to regulate gene 
expression unrelated to their provitamin A or antioxidant activity.
Another well-defined action of carotenoids is the prevention o f photosensitivity 
in patients with erythropoietic protoporphyria when given large doses of oral beta- 
carotene. This action is believed to be mediated by the quenching o f singlet oxygen in
10
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the skin, in a mechanism analogous to that which occurs in photosynthetic tissues (26). 
Pharmacological doses of BC ( ~ 180 mg/day) are given to these patients, and it is not 
clear i f  a similar protective process occurs in people without photosensitivity who have 
a much lower BC intake.
The interest in the actions and functions o f BC have been sparked, largely, by 
the proposition that dietary BC may materially reduce human cancer rates, put forth in 
1981 by Peto et al. (1). Since that time, there have been numerous repons of 
associations between increased consumption of carotenoid-rich foods and a decreased 
incidence o f chronic diseases such as cataract, macular degeneration, cancers of the 
oral cavity and cervix, and coronary hean disease (27). While the evidence strongly 
indicates that increased consumption of fruits and vegetables is associated with a 
decreased incidence of chronic disease, intervention studies which have supplemented 
populations with BC have returned conflicting results.
The Linxian China study (28) provided supplementation o f BC, vitamin E, and 
selenium to a marginally malnourished population, and found decreased mortality due 
to gastric and total cancer. The Physicians' Health Study (29), on the other hand, was 
a twelve year study in which male physicians were provided BC supplementation. This 
study showed that BC had neither a positive or negative effect on the incidence of 
cancer or heart disease. A third study, the Alpha-Tocopherol, Beta-Carotene Cancer 
Prevention study (30), conducted in Finland suggests that supplementary BC increased 
the risk o f lung cancer in high-risk groups. Thus, it is not clear whether BC affords 
any protection against the onset o f chronic disease or i f  it may be harmful in some
11
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situations. Additionally, BC may simply serves as a biomarker for some other 
protective agent or habits.
While many of the associations between carotenoids and decreased disease 
incidence have been interpreted to mean that carotenoids are protective, the possibility 
remains that these are only associations, which may not be causally related. Krinsky 
(4) reviewed the antioxidant effects and actions o f carotenoids associated with 
inhibition o f mutagenesis and malignant transformation, and concluded that while there 
is ample evidence that carotenoids can act as an antioxidant in vitro, there is a need for 
clear-cut studies indicating whether or not carotenoids behave as antioxidants in vivo.
Absorption, Transport, and Tissue Accumulation
Beta-carotene is a normal constituent o f the blood and other tissues of humans, 
cows, and ferrets, but not most rodents. Indeed, one o f the challenges of BC research is 
in finding a suitable animal model for studies where humans cannot be used. Many 
animals either do not absorb BC or are extremely efficient in convening it to retinol, 
resulting in little or no intact BC being found in the plasma or tissue. The absorption 
and transport o f BC has been studied extensively in humans, while there is limited 
information about tissue accumulation because o f the difficulty in obtaining tissues for 
analysis. Animal models for human BC metabolism have been generally limited to 
cows, particularly preruminant calves which have digestive systems more like humans 
than do mature cows which are ruminants, and ferrets. Both o f these species have been 
shown to absorb and accumulate intact BC (31,32). Other animals, such as rabbits, 
respond to dietary BC with increased serum retinoic acid levels, but do not absorb or 
accumulate detectable levels of BC (33).
12
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Human. Because it is an extremely lipophilic molecule, BC is associated with 
lipoproteins in plasma and the lipid portions o f cells, including membranes (both cell 
and organelle) and lipid droplets in adipose and steroidogenic tissues. The absorption 
o f BC is, therefore, dependent on the presence o f dietary fat reflecting its transport into 
the intestinal mucosa via micelles. Prince and Frisoli (34) showed that a single dose of 
BC (50 mg) consumed in the absence o f dietary fat resulted in no appreciable change in 
serum BC. However, the same dose, when given with 200 g o f fat, resulted in a 2.5- 
fold increase in serum BC concentration. They also demonstrated, via remittance 
spectroscopy, that BC accumulated in the skin o f subjects on chronic supplementation, 
though the effect was delayed by two weeks as compared to the serum response.
Once absorbed by the intestine, BC is secreted in chylomicrons into the lymph. 
Absorbed BC is first detectable in the triglyceride-rich lipoprotein fraction which is 
made up predominantly of chylomicrons, their remnants, and very low-density 
lipoproteins (VLDL) secreted by the liver (35). Beta-carotene associated with high- 
density lipoproteins (HDL) likely comes from chylomicrons during the transfer o f 
surface components from chylomicrons to HDL and as a result o f catabolism of the 
triglyceride-rich lipoproteins (36). Ultimately, BC accumulates in the tissues, 
primarily adipose, liver, and muscle, with the highest tissue concentrations occurring in 
the corpus luteum and adrenal glands (6 ).
One difficulty with studies o f BC absorption, has been the reliance on serum 
appearance o f intact BC as an indicator o f absorption. Some BC may be converted to 
retinol in the intestinal mucosa, and secreted in the form of retinyl esters as described 
above. Indeed, large inter-subject variability has been observed in the serum response
13
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to supplementation with oral BC (37-40). Whether this variability is due to differences 
in the efficiency of conversion o f BC to retinol, or to differences in the absorption of 
BC into the intestinal mucosa remains in dispute (41).
The use o f labeled BC may help answer the question o f just how much of a dose 
o f BC is absorbed intact, and how much is converted to retinol after absorption. In a 
study of one individual consuming a single dose of beta-carotene-d8 , a stable deuterated 
BC isotope, Novotny et al. (42) were able to construct a compartmental model o f BC 
metabolism. They concluded that 22% of a 40 mg BC dose was absorbed: 17.8% as 
intact BC and 4.2% as retinoid. In agreement with the previous studies, they saw an 
initial increase in chylomicron BC concentration followed by an increase in the other 
lipoprotein fractions. The residence time of BC in the body was estimated to be 51 
days, reflecting a stable tissue reserve of BC which requires time to deplete.
Cows. Many studies have focused on the suitability o f the pre-ruminant calf as 
an animal model for studying carotenoid metabolism. Adult cows, like all ruminants, 
have a four-compartmented stomach which is quite different than monogastric animals 
such as humans. However, the immature ca lf s digestive tract is not fully developed 
and they are considered functional monogastrics. While adult cows do absorb intact 
BC, the preruminant calf is a better model for studying BC absorption. Poor et al. (43) 
demonstrated that calves given a single-dose BC supplement showed serum response 
peaks at 12 and 30 hours post-dosing, similar to what is seen in humans. Additionally, 
serum data from the calves could be fitted to a two-compartment model, yielding an 
elimination constant similar to reported human values. They also showed that intact 
BC accumulated in adrenal, liver, spleen, lung, adipose, and kidney tissues. While
14
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there are many similarities between the humans and preruminant calves, their 
lipoprotein profiles are very different. Bovine HDL is easily distinguished from human 
HDL because of the elevated proportion o f cholesteryl ester found in the cow. Bovine 
HDL accounts for 80% o f total lipoproteins, while in humans, HDL accounts for only 
about 30% of total lipoproteins (44).
Because o f these differences, approximately 60% o f the BC in bovine serum is 
associated with H DL (45), while in humans only —23% o f serum BC is associated 
with HDL (36). As expected, because o f their compositional similarity to human LDL, 
bovine HDL o f larger size and higher lipid content have a higher BC concentration 
(46).
The accumulation o f BC within the tissues o f the bovine has been demonstrated 
in several studies. Poor et al. (43) showed that adrenal tissue showed increases in the 
BC concentration 24 hours after a single oral dose (20mg) o f BC and remained elevated 
11 days later. Liver, spleen, and lung BC concentrations were also elevated at 24 
hours post-dosing, and then rapidly declined. Adipose and kidney BC concentrations 
peaked at 72 hours and 144 hours post-dose, respectively.
Chew et al. (45) studied the uptake o f BC by blood cells, plasma, and 
lipoproteins in preruminant calves given either single or multiple oral doses of BC. 
They found that the relative increase in BC associated with the lipoproteins was greater 
for LDL than for HDL or VLDL. Orally administered BC also resulted in an increase 
in the BC concentration of lymphocytes, but not neutrophils or erythrocytes. The 
increase in the BC concentration of the lymphocytes was largely due to increases in the 
BC content o f the mitochondrial and nuclear fractions o f the lymphocytes.
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Hoppe et al. (47) also demonstrated an increase in plasma and tissue BC 
concentrations and liver vitamin A as a result o f supplementing preruminant calves with 
orally administered BC. A dose-dependent accumulation o f BC was found for liver, 
heart, lungs, adrenals, and adipose tissue.
Thus, the functionally monogastric calf may be a useful model for studying the 
absorption, transport, and tissue accumulation o f carotenoids and particularly BC. 
While the mature cow is not monogastric, it does absorb and accumulate intact 
carotenoids, including BC, making it a potential model for examining the functions of 
BC in tissues. Indeed, because of its high consumption o f plant matter, the cow has 
extremely high BC concentrations, with the highest being found in the adrenals and 
corpus luteum.
Corpus Luteum
The corpus luteum (CL), first described by de Graaf, is a transient steroidogenic 
tissue which is formed in the mammalian ovary subsequent to ovulation. In non-fertile 
cycles it begins to regress prior to the next ovulation, while in fertile cycles it continues 
to produce pregnancy-sustaining progesterone.
The CL is essentially a differentiated follicle in which the theca and granulosa 
cells o f the follicle give rise to the small and large steroidogenic luteal cells, 
respectively, after ovulation. In addition to these steroidogenic luteal cells, which 
make up -7 0%  o f the volume of the CL, the CL contains macrophages, fibroblasts, 
and endothelial cells. While large luteal cells account for only 3% of the luteal cells, 
they make up -40%  of the volume o f the CL, and are responsible for most o f the 
basal secretion o f progesterone. Small luteal cells also produce progesterone and are
16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
highly responsive to luteinizing hormone (LH), the major luteotropin in cattle (48). 
The ratio o f small to large luteal cells decreases as the CL ages as small luteal cells 
grow in size (49).
The process of luteinization, the differentiation of the follicle into the CL, is 
associated with the surge in LH concentration just prior to ovulation and results in the 
morphological and functional changes to the follicular cells. These changes result in 
the structural reorganization o f the cells and the production o f large quantities of the 
steroid hormone progesterone.
Several studies have demonstrated the relationship between the CL, 
progesterone, and successful pregnancy. Staples and Hansel, in 1961, examined the 
effects o f oxytocin injection, which inhibits CL development, on embryo survival 15 
days after insemination in 70 Holstein heifers. They determined that the threshold of 
CL progesterone necessary for embryo survival at fifteen days is 100 pg (50).
In a 1967 study, Estergreen et al. (51) performed ovariectomy o f forty-one 
cows at 48-268 days of pregnancy. Prior to 165-180 days o f pregnancy, the corpus 
luteum was essential to maintaining the pregnancy. Thereafter, a viable fetus was 
sometimes maintained after removal o f the CL, but the CL was necessary to prevent 
shortened gestations.
Progesterone supplementation after insemination was shown to increase 
pregnancy rate to 60% compared to 30% in untreated controls and it also increased 
plasma progesterone concentrations (52). Lamming et al. (53) found that cows which 
fail to maintain early embryos have a small but measurable depression in progesterone 
output, though not sufficient to be the sole explanation.
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Progesterone production by the bovine CL is regulated primarily by LH. 
Luteinizing hormone, a peptide hormone originating in the anterior pituitary, binds to 
LH receptors on the cells o f the CL and leads to an increase in progesterone secretion. 
Binding o f LH to its receptors activates adenylate cyclase thereby increasing intracellu­
lar cAMP concentration and activating protein kinase A. The active protein kinase 
leads to increased protein synthesis, increased cholesterol esterase activity, increased 
activity o f the cholesterol side-chain cleavage complex, increased transport of 
cholesterol into the mitochondria, and ultimately increased progesterone synthesis and 
secretion (54).
When fertilization and embryo formation does not occur, the uterus releases 
prostaglandin F2a (PGF2a) which inhibits the secretion o f progesterone by the CL and 
causes the loss o f luteal tissue (luteolysis). The anti-steroidogenic effects of PGF2a are 
believed to be mediated by the inhibition o f cholesterol transport to the steroidogenic 
enzymes. Luteolysis is manifested by a decrease in luteal blood flow and apoptotic 
death o f the cells o f the CL (55).
Steroidogenesis. The principle function o f the CL is the production and 
secretion of the steroid hormone progesterone which inhibits release of gonadotropic 
hormones by the anterior pituitary and prepares the uterus for implantation of an 
embryo. Because o f the need to produce large quantities o f progesterone, the CL is a 
metabolically active tissue characterized by a high blood flow and luteal cells which 
contain large numbers o f mitochondria, lipid droplets, and smooth endoplasmic 
reticulum.
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Like all steroidogenic tissues, the CL relies on a supply o f cholesterol as its 
precursor for steroid synthesis. In the rat, the CL is dependent on cholesterol supplied 
by plasma lipoproteins, primarily HDL (56,57). Similarly, bovine luteal cell grown in 
culture have been shown to utilize cholesterol from both LDL and HDL to increase 
progesterone production (58). In a review of the subject, Grummer and Carroll (59) 
concluded that lipoproteins provide the majority o f cholesterol for steroid biosynthesis, 
and that trophic hormones increase lipoprotein binding, internalization, degradation, 
and conversion o f lipoprotein-derived sterol to steroids.
Cholesterol is extracted from the circulating lipoproteins or entire lipoproteins 
are internalized and stored intracellularly. Cholesterol is then transported into the 
mitochondria to undergo the first committed and rate-limiting step o f steroidogenesis, 
side-chain cleavage. The transport o f cholesterol into the mitochondria is highly 
regulated and is responsible for the rapid increase or decrease in steroid synthesis in 
response to hormones (60). McLean et al. (61) showed that in the rat CL, estradiol 
stimulates progesterone synthesis by increasing the mitochondrial content o f sterol 
carrier protein-2 without affecting other steroidogenic enzymes. Thus, the increase in 
progesterone synthesis was due to an increase in the availability o f cholesterol to the 
mitochondria.
In the cow, a protein, steroid acute regulatory protein (StAR), transfers 
cholesterol from the outer to the inner mitochondrial membrane to initiate 
steroidogenesis. Corpora Iutea from cows treated with PGF2a exhibited a 50% decline 
in StAR mRNA over 12 hours, while other steroidogenic enzyme mRNA showed no 
change. The decline in StAR mRNA was paralleled by a decline in progesterone.
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indicating a regulation of progesterone synthesis by control o f the cholesterol supply 
(62).
Once in the mitochondria, cholesterol side-chain cleavage cytochrome P-450 
enzyme (P450scc) (63) catalyzes the conversion o f cholesterol to pregnenolone. This 
reaction, three successive monooxygenations, requires electrons which are transferred 
from NADPH to adrenodoxin reductase and to P450scc by adrenodoxin (Adx). 
Adrenodoxin acts as a shuttle transferring single electrons from adrenodoxin reductase 
to P450scc (64). The average relative concentrations of adrenodoxin reductase, Adx. 
and P450scc in the CL is 1:2.5:3, indicating that Adx and P450scc are present in 
approximately equimolar quantities (65).
While it appears that the primary acute regulation of steroidogenesis is at the 
level o f substrate availability (i.e., StAR regulation), changes in the concentrations of 
specific steroidogenic enzymes occur during the ovarian cycle. These changes in 
specific contents are reflected in the changes in the types o f steroids produced. 
Specifically, by the mid-luteal phase, concentrations o f Adx and P-450scc have 
increased 15 and 12-fold, respectively, compared to follicular and early-luteal levels. 
These changes accompany the dramatic increase in progesterone production (66). It 
appears that the acute regulation of steroidogenesis is accomplished by controlling the 
transport o f cholesterol from the outer to inner mitochondrial membrane, and that the 
long-term steroidogenic capacity o f a cell is determined by the concentration of the 
steroidogenic enzymes (63).
The process of electron transfer has been shown to leak electrons and generate 
oxygen free radicals under certain conditions in vitro. Hanukoglu et al. (67) suggested
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that it was possible that the high levels o f antioxidants found in steroidogenic tissue 
protected against damage from such radicals.
Numerous studies have examined the role o f oxygen radicals and antioxidants in 
controlling steroidogenesis in the corpus luteum o f rats. Riley and Behrman observed 
that the generation o f hydrogen peroxide (H20 2) in rat luteal tissue is an early and 
sustained component o f CL regression (68) and that H20 2 inhibits steroidogenesis by 
blocking intracellular transport of cholesterol to mitochondria or translocation of 
cholesterol across the outer mitochondrial membrane (69). It appears that this 
inhibition o f cholesterol transport is mediated by the inhibition o f rapidly inducible 
proteins analogous to StAR (70).
Beta-carotene and fertility 
Corpus luteum is Latin for "yellow body"; a name derived from the yel­
low/orange appearance of the bovine CL. This coloration is due to a high 
concentration of carotenoids, mainly beta-carotene, found in the bovine and human CL. 
This has led to studies attempting to elucidate the metabolic fate o f beta-carotene in the 
CL and its possible relationship to CL function.
The bovine CL has been shown to have relatively high concentrations of 
carotenoids and retinal (71-73). It has also been shown that the bovine corpus luteum 
possesses the ability to convert beta-carotene into retinal and retinol (72,74,75).
Gawienowski et al. (72) demonstrated in 1974 that bovine corpus luteum slices 
are able to convert radiolabeled beta-carotene to retinal. In 1983, Sklan (75) 
demonstrated carotene cleavage using homogenized CL. This study compared corpus 
rubicans (early CL), mid-ovulation CL (7- 12d post ovulation) and regressing CL (<3d
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prior to complete regression). The data suggest that the mid-ovulation CL has greater 
carotene cleavage activity than either o f the other two CL types. Because only two 
corpora rubicans and two regressing CL vs. 12 midovulation CL were used, the results 
were not statistically significant, however the results do suggest that BC metabolism 
may be associated with the functioning o f the CL.
Talavera and Chew (76) demonstrated that retinol, retinoic acid and beta- 
carotene, added to culture medium, each stimulate progesterone secretion by porcine 
luteal cells in vitro. Beta-carotene showed the most marked increase, stimulating 
progesterone secretion 10-fold. While each o f the three stimulated progesterone 
secretion, the fact that beta-carotene had the largest effect led the authors to conclude 
that beta-carotene may play a very important role in regulating luteal cell function.
Yokoe and Takenaka (77) reported that the concentrations o f carotenoids and 
Vitamin E in the human CL increase with CL development, peaking at the mid-luteal 
phase. During in vitro experiments, they determined that Vitamin E may play a role in 
protecting microsomal membranes from superoxide radical produced during the 
aromatization process o f steroidogenesis. They additionally postulated that carotenoids 
may protect cytoplasmic membrane from singlet oxygen generated by steroid- 
hydroxylation.
Based on this information, it is clear that CL contains high concentrations o f 
beta-carotene, much o f which is contained in the mitochondria and microsomes, centers 
of steroidogenic activity (73). Additionally, the CL has the capability to metabolize the 
BC. Beta-carotene. retinol and retinoic acid have been shown to influence progesterone 
production in vitro and retinol has long been considered to have a role in reproduction.
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Taken together, this suggests that the accumulation, distribution and metabolism of 
beta-carotene and the retinoids may be regulated to meet some specific purpose. 
Indeed, Aten and colleagues (78) concluded that in the rat the antioxidant reserve of the 
ovary is in a dynamic state and may be endocrine-regulated.
While the hypothesis that BC may have a functional role in the CL is intriguing, 
studies which have examined the relationship between BC and fertility in cows have 
produced contradictory results (79-81). In a review of the subject in 1982, Hemken 
and Bremel reported that a number o f studies from Germany had demonstrated 
increased fertility in cows supplemented with beta-carotene, even though the diets were 
adequate in Vitamin A. However, a similar study from Israel found no beneficial 
effects (81).
Graves-Hoagland et al. (80) measured plasma BC and vitamin A in 39 cows 
and correlated these values with in vivo progesterone production following 
gonadotropin-releasing-hormone-induced LH release. They found that progesterone 
production was positively correlated with beta-carotene concentration and negatively 
correlated with vitamin A.
Jackson (82) fed three groups o f cows low BC diets for varying periods (5, 4, 
or 2 weeks) and then synchronized their estrus and inseminated them. Plasma BC 
levels declined in all groups, and was directly correlated with length o f time to 
conception. Cows with the highest BC levels conceived on the first insemination, 
while those cows with the lowest BC levels required repeated services or did not 
conceive. The number of cows in the study was small (15), but the results did suggest 
a role for BC in fertility.
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Ascarelli et al. (81) fed cows supplemental beta-carotene (>500 mg/day) and 
compared reproductive parameters of this group to an unsupplemented control group 
receiving a ration o f low BC content. Their results are inconclusive in that they saw an 
increase in conception rates with supplementation, but only in younger cows during the 
first half o f the experiment. It is not clear what factors (seasonal, etc.) may have 
influenced their results.
Folman et al. (83) reviewed the case for beta-carotene’s enhancement o f fertility 
in cows and found that in some experiments, where the basal BC levels were below 0.5 
ug/ml. BC supplementation increased fertility. However, there was no case in which 
fertility was affected when plasma BC exceeded 1.5 jig/ml. This suggests some 
minimum requirement for BC, above which no effects o f supplementation will be 
apparent.
Given the oxidative nature o f steroidogenesis and the antioxidant properties of 
BC, it is reasonable to examine the effects o f BC on steroidogenesis. Covalent cross- 
linking between P450scc and adrenodoxin has been shown to occur when bovine luteal 
cells are cultured (84). In the study. Western immunoblotting after gel electrophoresis 
under denaturing conditions was used to probe cultured cells for P450scc and 
adrenodoxin proteins. In addition to a reactive band at the appropriate relative 
molecular mass (Mr), 49 kDa and 14 kDa, for their respective proteins, both antibodies 
reacted with a protein o f higher Mr (63 kDa). This corresponds to the weight obtained 
when P450scc and adrenodoxin are chemically cross-linked. The degree of cross- 
linking increased with time in culture, while the level o f BC in the cells decreased with 
time in culture. Supplementation of the medium with BC, but not alpha-tocopherol or
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ascorbic acid, inhibited the degree of cross-linking. The authors thus conclude that 
BC’s role in the corpus luteum is to inhibit the cross-linking o f the two enzymes, 
thereby retaining steroidogenic activity. This cross-linking has also been observed in 
vivo, in cows fed relatively high amounts o f concentrates (i.e., grain) (R. Rodgers, 
personal communication). [Concentrates tend to have a lower carotenoid concentration 
than do forages, such as hay and grass silage. 1 This study is the first that suggests a 
specific mechanism by which beta-carotene might be related to progesterone synthesis.
Present Study
There is continued interest in the role o f BC within tissues, in order to 
understand the possible mechanisms underlying the reported associations between BC 
and disease incidence in humans. For ethical and practical reasons, the study o f BC 
metabolism in human tissues is very limited. It is therefore necessary to develop an 
animal model which absorbs and metabolizes BC in a manner similar to humans. The 
cow is one such model.
In addition to providing a model for human BC metabolism, the reported 
associations between BC and fertility in the cow are deserving o f further study. 
Fertility, like the diseases in humans reported to be associated with BC, is a 
multifactorial process. This means that BC may play only a small role in one aspect of 
fertility, and its effects may only be apparent when other conditions are just right. This 
may explain the discrepancies between the various studies examining this issue.
Because of BC’s ability to act as an antioxidant, the oxidative nature o f 
steroidogenesis, the high concentration of BC in the CL, and the known role o f the CL 
in fertility, the CL may prove to be an excellent model in which to study BC.
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Specific Aims
With this in mind, the following study was designed to develop the bovine CL 
as a model for the study of tissue metabolism and function of BC and to elucidate a 
mechanism whereby BC might influence progesterone production or fertility by 
addressing the following specific aims:
1. Determine the relationship between dietary, plasma, lipoprotein, and corpus luteum 
concentrations o f beta-carotene, and the variability in this relationship between 
cows.
2. Determine the subcellular distribution o f beta-carotene within the bovine corpus 
luteum.
3. Determine the relationship between dietary, plasma, lipoprotein, or corpus luteum 
concentrations o f beta-carotene and plasma progesterone concentration in the cow.
4. Determine the effect o f varying dietary beta-carotene levels on the cross-linking of 
adrenodoxin and cytochrome P450 side-chain cleavage, two steroidogenic enzymes, 
in the corpus luteum.
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CHAPTER II
MATERIALS AND METHODS 
Experimental Design
Preliminary experiments
Preliminary experiments were conducted to determine the optimum method for 
CL beta-carotene quantitation, the intra- and inter-cow variability in plasma and CL 
beta-carotene concentration, and the relationship between plasma and CL beta-carotene 
concentrations. Five non-lactating Jersey cows were housed at the University of New 
Hampshire Dairy Teaching and Research Center in one pen o f a bedded-pack bam. 
The cows were allowed ad libitum access to feed (typical dry cow total mixed ration 
containing haylage, com silage, com meal, soybean meal, and minerals) and water. 
Corpora lutea and plasma were collected ten days after cows exhibited standing heat. 
Supplementation experiment
A supplementation experiment was conducted to determine the relationship 
between dietary and plasma and CL beta-carotene, the subcellular localization of beta- 
carotene within the CL, and the effect o f dietary beta-carotene on the cross-linking of 
adrenodoxin and cytochrome P-450scc. Five non-lactating Jersey cows (different from 
those used in preliminary experiments) were housed at the University of New 
Hampshire Dairy Teaching and Research Center in one pen of a bedded-pack barn. All
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procedures involving animals were approved by The University of New Hampshire 
Animal Care and Use Committee. Cows were fed once daily in individual feed bins. 
Access to feed was regulated by headgates (American Calan, Inc.) to individual feed 
bins which were keyed to open only when triggered by the transponder worn by the 
assigned cow. This assured that each cow was able to eat only that feed intended for 
her.
Cows received daily approximately sixteen pounds (as fed) of a basal ration 
consisting of 12 pounds chopped wheat straw, 3 pounds com silage. 0.6 pounds 
soybean meal, and 0.6 pounds Sunshine Plus® pellets (Blue Seal Feeds, Londonderry, 
NH) mixed together. This was top-dressed with 2.6 pounds o f Coarse 20® (Blue Seal 
Feeds), a molasses-coated grain. This ration was formulated to meet all essential 
requirements o f the National Research Council (1989), while providing a minimal 
amount o f beta-carotene.
This experiment lasted for twenty-eight weeks, and was divided into four blocks 
o f seven weeks each. Top-dressed grain was supplemented with beta-carotene, in the 
form of water-soluble beadlets (kindly donated by Roche, Nutley, NJ), to create five 
treatment levels o f 0.0, 1.6, 8.0, 16.0, or 80.0 mg o f supplemented beta-carotene per 
day. Each cow was randomly assigned to receive one o f these treatments for each 
seven-week block, such that, only one cow received any one concentration during each 
block and each cow received four o f the five different treatments over the course o f the 
experiment. This is a Latin Square design with one row missing (Table 7)(85); the 
sums of squares can be partitioned into four terms: block, cow, treatment, and error.
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Cow 1 Cow 2 Cow 3 Cow 4 Cow 5
Block 1 80 1.6 16 8 0
Block 2 16 0 8 1.6 80
Block 3 0 8 80 16 1.6
Block 4 1.6 16 0 80 8
Table I  Incomplete Latin Square design showing supplemental dietary beta-carotene
(mg/d) fed to cows during the supplementation experiment.
Sample Collection
Weekly blood samples were collected via jugular or tail venipuncture into 
vacutainers containing heparin. Plasma was separated from red blood cells by 
centrifugation at 2500 rpm, 4°C for 15 minutes, and was aliquotted and stored at -70°C 
for subsequent beta-carotene analysis.
Each cow was injected, intramuscularly, with 5 mL Lutalyse® (The Upjohn 
Company, Kalamazoo, MI) providing 25 mg dinoprost tromethamine (Prostaglandin F2 
alpha) approximately fourteen and twenty-five days prior to harvest o f the corpora lutea 
(CL). These injections ensured that all five cows would be at the same stage of the 
estrous cycle, so that CL harvest could take place within a three-day window. Corpora 
lutea were obtained via enucleation per vaginum during the mid-luteal phase (9-12 days 
after ovulation) o f the estrous cycle. Blood samples were collected from the jugular 
vein into vacutainers containing heparin just prior to CL harvest, and plasma was 
isolated and stored as described above.
Immediately after harvest, the papilla was removed from the CL, the CL was 
bisected, drained o f any fluid and weighed. Portions o f the tissue were flash frozen in 
liquid nitrogen for subsequent immunoblotting or placed in fixative. 10% neutral
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buffered formalin or glutaraldehyde (3%) in cacodylate buffer (0 .1M), for subsequent 
histological or electron microscopical examination, respectively. The remaining tissue 
was placed in ice-cold medium (Ham’s F-12 with L-glutamine and without phenol red, 
Life Technologies, Grand Island, NY) containing gentamicin (3 mg / 100 ml, Life 
Technologies) and transported back to the lab.
Tissue Culture
Approximately 1.0 g o f CL tissue was placed in a petri dish, connective tissue 
was removed, and the CL tissue was weighed. The CL tissue was then minced with 
two sterile scalpels to pieces smaller than 1.0 mm3. The minced tissue was placed in a 
conical centrifuge tube containing 25.0 ml medium with gentamicin and 0.5% bovine 
serum albumin (BSA, Sigma Chemical, St. Louis, MO) and agitated in an orbital 
shaker bath (2500 rpm, 37° C) for two minutes. After allowing the tissue to settle, the 
medium was aspirated and replaced with fresh medium. To this, collagenase (Type I, 
Worthington Biochemical, ) was added according to the following formula:
(2000) (weight of CL in grams) /  (activity of collagenase) =  mg of collagenase 
The tube was then agitated in an orbital shaker bath (2500 rpm, 37° C). Every fifteen 
minutes during the digestion, tissue was further dissociated by pipetting up and down 
with a small bore pipet. After 60 minutes, remaining tissue pieces were allowed to 
settle, and the cloudy medium was transferred to a clean tube and centrifuged at 600 x 
g for 8 minutes. The supernatant was aspirated, the cell pellet gently resuspended in 10 
ml of Ham’s F-12 medium with gentamicin, and centrifuged 600 x g for 8 minutes. 
This process was repeated, typically two or three times, until the supernatant appeared 
clear. The supernatant was aspirated, and the cell pellet gently resuspended in 5.0 ml
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of medium with gentamicin and 10% fetal bovine serum (FBS, Sigma Chemical, St. 
Louis, MO). Cells were counted using a hemocytometer and viability determined by 
trypan blue exclusion. Flasks (25 cm2, Coming) were seeded with at least one million 
viable cells and brought to a final volume o f 5.0 ml with medium containing 
gentamicin and 10% FBS (58). Flasks were incubated at 37° C in a 5% C 02 
atmosphere with 95% humidity. Approximately 16-18 hours later, non-attached cells 
were removed by aspiration, the monolayer was rinsed with medium containing 
gentamicin, and fresh medium (with gentamicin and 10% FBS) was applied. Forty- 
eight hours after the initial seeding, the medium was aspirated, the cell monolayer 
rinsed with Hank’s Balanced Salt Solution without Ca2+ and Mg2+ (HBSS modified), 
and the cells harvested via trypsinization. The cell suspension was centrifuged and the 
resulting cell pellet was resuspended in 1.0 ml o f lysing buffer (0.01 M phosphate 
buffered saline, 0.1 % sodium dodecyl sulfate, 1 % sodium cholate) and the lysate stored 
at -70°C for subsequent immunoblotting.
Progesterone
Plasma
Plasma progesterone concentrations were determined utilizing the Milenia 
Progesterone enzyme immunoassay (Diagnostic Products Corporation, Los Angeles. 
CA). Data reduction was performed using 4-parameter logistic regression in SigmaStat 
(Jandel Corporation, San Rafael, CA).
Corpus Luteum
Corpus luteum progesterone content was determined by radioimmunoassay 
(RIA)(86). Corpus luteum tissue (50-200 mg) was homogenized in 3.5 ml PBS with
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0.1% gelatin and 0.1% sodium azide (PBSG) using a Polytron homogenizer. 
Subsequently. 100 (al o f the homogenate was extracted twice with 2.0 ml petroleum 
ether, the petroleum ether was evaporated, and the residue resuspended in 500 (al 
PBSG. This was diluted (lOOx) and 100 (al was analyzed in duplicate by RIA using 
tritiated progesterone (0.01 (aCi / assay tube) and anti-progesterone antibody (10,000x 
final dilution).
Subcellular Fractionation 
Crude subcellular fractions were prepared as previously described (45,73). 
Approximately one gram o f CL was homogenized in 5 volumes o f 0.25 M sucrose 
containing 10 mM HEPES and 1 mM EDTA. The resulting homogenate was 
centrifuged (600 x g for 10 min. at 4°C) and the crude nuclear pellet was separated 
from the supernatant. The nuclear fraction was further purified by homogenizing in 
1.0 ml o f 0.8 M sucrose containing 10 mM HEPES, 1 mM EDTA, and 1 mM MgCl2 
and centrifugation (67,000 x g for 30 min. at 4°C). The postnuclear supernatant 
obtained earlier was centrifuged (17,300 x g for 20 min. at 4°C) to obtain the 
mitochondrial pellet. The postmitochondrial supernatant was centrifuged (102,000 x g 




The procedure used to extract and quantify plasma beta-carotene is based on 
methods previously described (87). Four hundred |ul o f plasma was precipitated with
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200 |il o f 100% ethanol and 200 pi o f an ethanolic solution o f retinyl acetate and 
tocopherol acetate as an internal standard, and then extracted twice with 2.5 ml of 
hexane. The hexane layer was collected in an amber glass vial with a teflon-lined cap 
(Scientific Specialties, Randallstown, MD) and evaporated under a stream o f nitrogen 
(N2) at 30°C. The sample was reconstituted in 200 pi o f 100% ethanol, thus 
concentrating the sample twice.
High-density Lipoprotein
To 500 pi o f plasma, was added 50 pi o f HDL Cholesterol Reagent (dextran 
sulfate (lOg/L) and Mg ions (0.5 mol/L), Sigma) to precipitate the low- and very low- 
density lipoproteins (88). After vortexing and incubating for five minutes at room 
temperature (RT), the solution was centrifuged (1500 x g, 10 min, RT). Four hundred 
pi o f the supernatant (HDL containing solution) was removed and extracted as 
described for plasma above.
Tissue
Approximately 0.1 to 0.3 g o f CL tissue was minced, weighed, and placed into 
a glass homogenization pestle with 1.0 ml o f 0.5% collagenase (Type la, Sigma) in 
phosphate buffered saline (PBS) and 25 pi o f 25% ascorbate (89). Digestion was 
allowed to take place for one hour in an orbital shaker bath (2500 rpm, 37°C). The 
solution was homogenized with a drill-mounted Teflon mortar (three strokes, 1500 
rpm) and 1.0 ml o f 100% ethanol was added to precipitate the proteins. The resulting 
solution was extracted three times with 2.5 ml o f hexane, and the hexane extract was 
pooled in an amber vial. The hexane was subsequently evaporated at 30°C under N2,
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and the resulting residue was resuspended in ethanol (1.0 ml per gram of tissue 
digested) for analysis by HPLC.
Subcellular Fractions
Subcellular fractions were precipitated with the ethanolic internal standard and 
extracted twice with 2.5 ml of hexane. The hexane was subsequently evaporated at 30° 
C under N2, and the resulting residue was resuspended in ethanol for analysis by 
HPLC.
Beta-carotene Analysis 
The HPLC (high performance liquid chromatography) system (Beckman 338) 
was a reverse-phase HPLC with a C18 Baker Bond wide pore (5 |j.m) column (J.T. 
Baker, Phillipsburg, NJ), a variable wavelength spectrophotometer (Beckman 406), and 
a Beckman 167 Scanning Detector Module (Beckman Instruments, Wakefield, MA). 
The mobile phase was a gradient changing from solvent A (methanol and 0.1% 
ammonium acetate) to solvent B (methanol: methylene chloride (80:20) and 0.1% 
ammonium acetate) over the first four minutes o f the run. The wavelengths were set at 
292. 325. and 452 nm for detection o f tocopherol acetate, retinyl acetate, and beta- 
carotene, respectively. The flow rate was 1.5 ml per minute. Twenty p.1 o f sample 
was injected for each sample. Signal acquisition, integration, and beta-carotene 
quantitation were performed with an HP 3365 ChemStation (Hewlett-Packard. 
Burlington, MA) based on a standard curve. The internal standard was used to correct 
for any volume lost during preparation o f the sample. Throughout the research period, 
the laboratory participated in the micronutrients measurement quality assurance
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program sponsored by the National Institute o f Standards and Technology, 
Gaithersburg, MD.
Gel Electrophoresis
Frozen CL tissue was thawed and homogenized in 1.0 ml lysing buffer in a 
glass on glass homogenizing pestle. The homogenate was centrifuged (10000 x g, 10 
minutes) to remove particulate matter and the protein concentration was determined by 
the method o f Markwell (90). Homogenates were mixed with buffer (91) containing 
1% SDS, 0.2 M (3-mercaptoethanol, and 1 mM EDTA (Bio-Rad Laboratories, 
Hercules, CA) to give 5.0 or 50.0 pg protein per 25 pi solution for separation of 
adrenodoxin or cytochrome P-450scc, respectively. Samples were boiled for 10 min 
prior to electrophoresis on polyacrylamide gels (4% stacking gel and 10 or 15% 
separation gel for Adx or cytochrome P-450scc, respectively). Samples, pre-stained 
molecular weight markers (Broad range, Bio-Rad Laboratories), and protein standards 
(Adx purified according to protocol below) were electrophoresed for 2 hours at 100 
volts using a Bio-Rad Mini-Protean II electrophoresis system.
Electroblotting
Separated proteins were transferred from gels to nitrocellulose membranes (0.2 
or 0.45 pm pore size for Adx or cytochrome P-450scc, respectively). Transfer was 
accomplished using a Bio-Rad Mini-Protean II electroblotting system with 20% 
methanol. 10 mM Tris, 150 mM glycine solution. 4°C, 75mA for 16 hours (92).
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Western Immunoblotting 
Membranes were incubated in milk block solution (Kirkegaard-Perry 
Laboratories, Gaithersburg, MD) for I hour at RT and then with specific antibody 
(Adx antibody raised as described below and anti-rat cytochrome P-450scc from 
American Research Products, Belmont, MA) for two hours at RT. Membranes were 
washed three times, for 15 min, with wash solution (Kirkegaard-Perry Laboratories) 
and incubated with secondary antibody (alkaline phosphatase-labeled goat anti-rabbit 
IgG, Kirkegaard-Perry Laboratories) for 1 hour at RT. Membranes were washed three 
times, for 15 min, with wash solution and incubated with 5-bromo-4-chloro-3-indoyl- 
phosphate/nitroblue tetrazolium substrate (BCIP/NBT, Kirkegaard-Perry Laboratories) 
for approximately 15 min. or until color development was apparent.
Histology
Paraffin-embedded sections were prepared for histological examination by the 
Veterinary Diagnostic Laboratory at the University o f New Hampshire. Sections were 
stained with either hematoxylin and eosin (H+E) or Masson’s trichrome (93), and 
examined using an Olympus Model BHS System Microscope (Olympus Corporation. 
Lake Success, NY)
Transmission Electron Microscopy 
Tissues were fixed in glutaraldehyde (3%, Polysciences, Inc., Warrington, PA) 
in cacodylate buffer (0 .1M, pH 7.3) with CaCl2 (1 drop of 1% per 10 ml fixative) for 
four hours at RT. Tissue was rinsed four times with cacodylate-sucrose buffer (-3 0 0
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mOsm) and postfixed in 1% osmium tetroxide (0s04, Polysciences, Inc.) in 0 .1M 
cacodylate buffer (pH 7.2) for 1 hr at 4°C. The tissues were rinsed four times with 
cacodylate-sucrose buffer and dehydrated in a graded series o f ethanol dilutions (35 %, 
50%, 70%, 95%, and twice at 100%) for 15 min each and then placed in a transitional 
solvent, propylene oxide, for 15 min at RT. Tissue was then immersed in a mixture o f 
complete resin (Epon 812 with 40% dodecenylsuccinic anhydride, 60% nadic methyl 
anhydride, and 0.14 ml / 10 ml o f 2,4,6 tri-(dimethylaminomethyl) phenol) and 
propylene oxide (1:1 v/v) for 1 hour, followed by overnight infiltration with complete 
resin (94). Tissue was then embedded with fresh complete resin in (00) BEEM 
capsules (Polysciences, Inc.), placed in an oven at 60°C for 72 hrs to allow the resin to 
polymerize, and the BEEM capsules were removed from the solidified resin. Thin 
sections of 90-150 nm were cut using a Reichert-Jung Ultracut E (Cambridge 
Instruments, Inc., Deerfield, IL) with a diamond knife (Edgecraft Corporation, 
Avondale, PA) and mounted on 200 square mesh copper grids (Ernest F. Fullam, Inc., 
Latham, NY). The sections were stained with 2% aqueous uranyl acetate for 15 min at 
RT. rinsed in double distilled H20, followed by staining with aqueous lead citrate for 
30 min at RT in the presence o f sodium hydroxide pellets to prevent reaction with 
atmospheric C 02 (95). A ll stained tissues were examined and photographed with a 
JEOL 100S transmission electron microscope (JEOL, Inc., Peabody, MA).
Adrenodoxin Isolation and Antibody Production 
Adrenodoxin was isolated from bovine adrenals (PelFreez Biologies, Rogers, 
AR) by the method o f Orme-Johnson and Beinert (96). Whole bovine adrenals (500 
g) were homogenized in I liter o f buffer containing 0.05 M KCI with a Waring
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blender. The homogenate was centrifuged for 15 min at 1600 x g, and the pellet was 
resuspended in 500 ml o f buffer and centrifuged again. The supernatants were 
combined, chilled to 4°C, and 10 g diethyiaminoethyl cellulose (DEAE-cellulose, 
Sigma) were added while stirring. The solution was allowed to stir overnight at 4°C. 
The DEAE-cellulose, with adsorbed protein, was recovered by centrifugation at 1600 x 
g, 4°C for 10 min. The DEAE-cellulose was washed twice with buffer (0.1 M KC1) by 
resuspension and centrifugation. The DEAE-cellulose was transferred to a Buchner 
funnel, and the adsorbed protein was removed with three 100 ml washes of buffer (0.5 
M KC1). The resulting solution was diluted 5-fold with buffer (0.05 M KC1), any 
turbidity removed by centrifugation (14000 x g, 4°C, 30 min), and then passed through 
a column (2.5 x 15 cm) o f DEAE-cellulose equilibrated with buffer (0.05 M KC1). 
The column was washed with buffer containing 0.17 M KC1 (500 ml) and the brown 
protein was eluted with buffer containing 0.33 M KC1 (30 ml). This solution was 
passed through a Sephadex G-100 (Sigma) column (2.5 x 50 cm) equilibrated with 
buffer containing 0.1 M KC1 and 0.05 M Tris, pH 8.1. The brown protein was eluted 
with equilibrating buffer, collected in approximately 30 ml, and passed through a 
column (1.5 x 8 cm) o f DEAE-cellulose equilibrated with buffer (0.05 M KC1). The 
column was washed with equilibrating buffer and the brown protein was eluted with ~
4 ml of buffer containing 0.5 M KC1. The resulting solution was dialyzed overnight at 
4°C against 500 volumes of 0.1 M Tris, pH 8.1, under nitrogen. The resulting 
solution was assessed at The University o f New Hampshire Protein Sequencing 
Facility, using a PI 2090 Integrated Micro-Sequencing System (Porton Instruments) to 
verify the presence o f adrenodoxin.
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Antibodies to bovine adrenodoxin were prepared by polyclonal antibody 
production (97). Two New Zealand White rabbits, approximately four months old were 
immunized by subcutaneous injections with 2 mg bovine adrenodoxin, purified as 
stated above. The protein was emulsified in 1 mL of complete Freund’s adjuvant 
(Sigma) and 1 mL phosphate-buffered saline for the primary immunization. Two mL 
of the emulsion was injected at ~  20 sites (0.1 mL per injection site). The 
immunizations were repeated four times at two week intervals with incomplete 
Freund’s adjuvant. Blood samples (5-30 mL) were drawn with a 20 gauge needle from 
the central ear artery, and tested for the presence o f antibodies reactive with 
adrenodoxin, by enzyme-linked immunoassay (ELISA), at one week intervals 
beginning 5-6 weeks after the initial immunization. Acepromazine maleate (0.1 mL, 
10 mg/mL) was injected into the marginal ear vein for vasodilation. The rabbits were 
exsanguinated by cardiac puncture eleven weeks after the initial immunization and 
antibody was purified by affinity chromatography.
Statistical Analysis
Data were analyzed using the PROC GLM module o f SAS (SAS Institute Inc., 
Cary. NC. Proprietary Software Release 6.11 Licensed to University Of New 
Hampshire, Site 0004324001.) and linear orthogonal contrasts were determined (85). 
Data were grouped according to the amount o f dietary BC fed to the cow during each 
block o f the supplementation experiment. Values are reported as least squares means ± 
SEM.
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CHAPTER III
RESULTS
Extraction and Quantification 
The extraction and quantification of BC from tissue is generally more 
complicated than extraction from plasma, because o f the various matrix components in 
tissue. In plasma, BC is associated with the lipoproteins and may be extracted with 
hexane following precipitation o f the plasma proteins with ethanol. In other matrices, 
there is the problem o f ensuring that the BC is free to partition into the hexane layer. 
Therefore, three different protocols were tested for the extraction o f BC from CL 
tissue: direct extraction o f homogenized tissue, saponification (the digestion of tissue 
with 10 N KOH prior to hexane extraction), and collagenase digest. Direct extraction 
proved impractical, because the hexane used in the extraction formed a gel with some 
component of the homogenized tissue. Saponification resulted in the splitting o f 
various peaks in the chromatogram, making it d ifficult to quantify BC, and was 
therefore not used (data not shown). The method chosen was the collagenase digest 
detailed in the material and methods section. Representative chromatograms show the 
baseline separation of those analytes identified and quantified (Figure 2). While not 
quantified, there was no apparent change in the shape o f the beta-carotene peak which 
might be indicative o f isomerization.
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To determine the number o f extractions needed to recover the BC from the CL, 
tissue was digested with collagenase, homogenized, and precipitated with ethanol, and 
the resultant homogenate was extracted nine times with 2.5 ml o f hexane. Each extract 
was then analyzed separately by HPLC to determine the BC concentration. The BC 
content o f the fourth through ninth extractions was below the lim it o f detection when 
analyzed separately, so these extractions were pooled. By dividing the BC content of 
each fraction by the total BC content o f all fractions, a percent of total BC recovered 
per fraction was obtained. The recovery was 58, 29, 8, and 5 % for the first, second, 
third, and fourth-ninth extractions, respectively (values are means of three trials). 
Subsequently, all CL homogenates were extracted three times with 2.5 ml o f hexane.
To establish the validity and estimate the analytical variability o f this method, 
BC was quantified ten times each (each analysis performed on a different day) in three 
corpora lutea, which had been minced fresh, and frozen in individual vials ( - 0 .1  g). 
The analytical variability in assessing the CL beta-carotene concentration was 
determined to be 4.4% (Table 2), so the method was accepted as valid. Once the 
protocol was accepted, all tissue was analyzed in duplicate (i.e., duplicate extractions). 
The variation in alpha-tocopherol and BC between duplicate extractions has remained 
below 5% (data not shown).
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Figure 2 Representative chromatograms. Representative chromatograms of 
corpus luteum (top) and plasma (bottom) are shown. The top panel in each 
chromatogram is channel A, which represents the sample absorbance at 292 nm. The 
bottom panel in each chromatogram is channel B, which represents the sample 
absorbance at 325 nm from 0-3 min and 452 nm after 3 min. Identified peaks are 
labeled with their compound name: retinol acetate, beta-carotene, alpha-tocopherol, or 
tocopherol acetate.
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CL Beta-carotene (nmol/g)
Replicate CL #1 CL #2 CL #3
1 87.125 110.325 96.378
2 84.321 115.236 100.598
3 86.467 120.586 92.786
4 94.904 105.647 95.888
5 95.453 110.594 103.674
6 91.676 115.389 91.357
7 93.546 117.845 97.685
8 88.734 108.397 94.265
9 91.424 102.348 98.674
10 96.060 106.380 101.356
Coefficient of Variation 4.3% 5.0% 3.8%
Table 2 Analytical variability. The analytical variability in quantitation o f the 
beta-carotene concentration within the bovine corpus luteum was determined by 
analyzing frozen tissue samples from three corpora Iutea. Each analysis for any one CL 
was performed on a different day. The coefficient o f variation is equal to the standarc 
deviation divided by the mean BC concentration determined for that CL expressed as a 
percent.
Inter- and Intra- cow Variability 
There is considerable variability in plasma BC concentrations in humans and in 
animals, which is difficult to account for by dietary intake alone. Accounting for this 
variability is important in assessing the number o f animals needed for an experimental 
protocol. Because o f this, and the fact that little is known about the variability o f BC 
concentration within tissues, preliminary experiments with five non-lactating Jersey 
cows were conducted to determine the variability in plasma and CL beta-carotene 
between cows and between sampling periods in the same cow (Table 3). The intra-cow 
variability was 12.9% and 18.3% and the inter-cow variability was 26.5% and 36.3% 
for plasma BC and CL BC, respectively.
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Cow-Sample (pmol/l) C.V. (% ) (nmol/g) C.V. (%)
1-1 10.912 125.126
1-2 10.154 115.625
1-3 9.539 5.5 107.222 6.3
2-1 17.090 217.854
2-2 12.381 248.399
2-3 12.693 15.3 162.112 17.1
3-1 9.980 75.626
3-2 10.208 172.050
3-3 6.413 19.6 130.157 31.3
4-1 7.728 86.581
4-2 6.611 105.239
4-3 9.520 15.1 70.541 16.2
5-1 7.423 143.557
5-2 8.498 200.345
5-3 9.222 8.8 125.368 20.4
Average C.V. (% ) 26.5 12.9 36.3 18.3
Table 3 Beta-carotene concentration variability. The variability in plasma and
corpus luteum beta-carotene concentrations was determined for a group o f five cows on
a typical dry cow ration. The coefficient o f variation is equal to the standard deviation
divided by the mean BC concentration expressed as a percent. The intra-cow
coefficient o f variation (C.V.) is the mean o f each cow’s individual C.V , while the
inter-cow C.V. is the variation between all measures.
Plasma Beta-carotene Depletion 
Because o f the accumulation of BC within the tissues, the adjustment o f plasma 
BC concentrations to dietary modification may take some time. To determine how long 
it would take for the plasma BC concentration to level out in cows being depleted o f 
BC, four cows were fed the basal ration, weekly blood samples were taken, and 
separated plasma was analyzed for BC concentration. Plasma BC concentrations 
decreased rapidly for the first three weeks, and then continued to decline more slowly.
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Plasma BC concentration leveled out at about seven weeks (Figure 3). In one cow 
(Cow#5) which was fed the basal ration for fourteen weeks, plasma BC concentration 
declined from 4.077 pmol/l to 2.278 pmol/l at the end o f seven weeks, and to 1.617 p. 
mol/1 at the end of fourteen weeks (Figure 4e). Seven weeks was selected as the time 
for each block in the supplementation experiment because it allowed sufficient time for 
recovery and healing between CL harvests, and the rate o f change in plasma BC 
concentration after this time point is small.
These data were also used to confirm that the basal ration, as formulated, would 
be sufficiently low in BC to cause a predicted serum response. During the depletion 
period, plasma alpha-tocopherol (AT) concentration was also measured. Plasma AT 
concentrations also declined during this period (36% reduction, data not shown). The 
decline in plasma AT was not anticipated and could confound the interpretation of any 
results due to changes in BC concentration, so the cows were fed Sunshine-Plus Pellets, 
a commercially-available AT supplemented grain, during the supplementation 
experiment to ensure that any effects seen were not due to AT depletion.
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Figure 3 Plasma beta-carotene depletion. The change in plasma beta-carotene 
concentration (pmol/1) in four cows fed the basal ration containing low dietary beta- 
carotene. The rate of decline in plasma beta-carotene decreases, such that plasma beta- 
carotene concentrations change little after about seven weeks.
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Supplementation Experiment 
For the supplementation experiment, a total of eighteen corpora lutea were 
collected, four each from three cows and three each from two cows. One cow appeared 
to have a cystic ovary at the time o f CL collection at the end o f the third block and the 
CL o f another cow, at the end o f the fourth block, was not retrieved due to a build up 
of scar tissue. Some cows failed to show behavioral estrus, so corpora lutea were 
obtained thirteen or fourteen days after the second Lutalyse© injection. Since Lutaiyse 
® is a prostaglandin which induces ovulation within 80 hours, the corpora lutea 
obtained were mid-cycle (9-11 days post-ovulation). When cows did show behavioral 
estrus, corpora lutea were obtained ten days later.
Plasma Beta-carotene 
The change o f plasma BC with dietary modification over time is shown in 
Figures 4a-4e. These data show the plasma response to four different levels of 
supplemental BC. For all treatments, there was an unexpected general increase in the 
BC concentration after week eight, and a general downward trend after week twenty. 
These changes coincided with a change in the lot o f straw which was being fed in the 
basal ration, suggesting that these variations were due to changes in the BC content of 
the basal ration. Because of this, the average plasma BC concentration observed for 
blocks two and three was greater than that for blocks one and four. As a consequence, 
during blocks two and three the CL beta-carotene concentration of cows receiving the 
lowest levels o f supplementary BC were higher than those of cows receiving the same 
levels during blocks one and four (Table 4).
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Plasma BC concentrations measured at the time o f CL harvest reflected the 
amount o f supplemental BC fed to the cow. Cows receiving the highest level o f dietary 
BC had significantly higher plasma BC concentrations than any other treatment level 
(p<0.01), but there was not a statistically significant difference between the four 
lowest treatment levels. However, orthogonal contrast analysis showed that there was a 
significant linear response to the level o f supplemental dietary BC (p<0.001) 
(Figure 5).
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Supplemental dietary beta-carotene
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Figure 4a Plasma beta-carotene timecourse (Cow#l). The change in 
plasma beta-carotene concentration (|imol/l) in Cow#l over the seven weeks 
preceding, and the twenty-eight weeks o f the experiment. Supplemental beta-carotene 
refers to the amount of beta-carotene fed per day in top-dressed grain during each 
seven week treatment period.
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Supplemental dietary beta-carotene
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Figure 4b Plasma beta-carotene timecourse (Cow#2). The change in plasma 
beta-carotene concentration (pmol/l) in Cow#2 over the seven weeks preceding, and 
the twenty-eight weeks of the experiment. Supplemental beta-carotene refers to the 
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Figure 4c Plasma beta-carotene timecourse (Cow#3). The change in plasma 
beta-carotene concentration (jim ol/l) in Cow#3 over the twenty-eight weeks of the 
supplementation experiment. Supplemental beta-carotene refers to the amount o f 
beta-carotene fed per day in top-dressed grain during each seven week treatment 
period.
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Supplemental dietary beta-carotene 
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Figure 4d Plasma beta-carotene timecourse (Cow#4). The change in plasma 
beta-carotene concentration (pmol/l) in Cow#4 over the twenty-eight weeks o f the 
supplementation experiment. Supplemental beta-carotene refers to the amount o f 
beta-carotene fed per day in top-dressed grain during each seven week treatment 
period.
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Supplemental dietary beta-carotene
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Figure 4e Plasma beta-carotene timecourse (Cow#5). The change in plasma beta- 
carotene concentration (pmol/l) in Cow#5 over the seven weeks preceding, and the 
twenty-eight weeks of the experiment. Supplemental beta-carotene refers to the 
amount o f beta-carotene fed per day in top-dressed grain during each seven week 
treatment period._____________
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Figure 5 Plasma beta-carotene. Plasma beta-carotene concentration (|imoI/l) 
on day of corpus luteum harvest grouped by supplemental dietary beta -carotene 
(mg/day) received in the preceding seven weeks. Values are least squares means ± 
SEM. n = 4 for each treatment. There was a significant linear response to the level of 
supplemental dietary beta-carotene (p<0.001).
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Corpus luteum BC 
(nmol/g)
3 4 0.0 1.267 4.762
5 4 8 1.521 7.073
1 4 1.6 0.968 8.922
2 1 1.6 0.709 11.035
3 1 16 1.421 15.939
4 1 8 1.040 16.388
5 1 0 0.916 18.077
1 3 0 2.279 19.568
4 2 1.6 1.230 21.101
5 3 1.6 2.019 25.121
3 2 8 1.923 26.212
2 2 0 1.150 32.901
I 2 16 2.599 39.745
4 3 16 2.399 41.135
2 3 8 2.009 53.017
I 1 80 3.835 53.283
5 2 80 3.849 57.770
4 4 80 5.828 58.445
2 4 16 1.588 No CL
3 3 80 4.416 No CL
Table 4 Beta-carotene concentrations by cow and block. Plasma and corpus 
luteum beta-carotene concentrations of cows on day of corpus luteum harvest during 
the supplementation experiment. Supplemental beta-carotene refers to the amount o f 
beta-carotene in top-dressed grain. Values are sorted by corpus luteum beta-carotene 
concentration (corpora lutea were not obtained from two cows, indicated by No CL).
Relationship between plasma and HDL beta-carotene 
Because o f the narrow range of BC concentrations (6.41-17.09 p.mol/1 plasma) 
in previous experiments (Table 3), preliminary experiments failed to show the 
significant relationship between plasma and HDL beta-carotene concentrations 
(Pearson's R =  0.456, p = .217). However, when this data was combined with the 
data from the dietary BC manipulation experiment, which resulted in a broader range
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o f BC concentrations (0.96-17.09 (j.mol/1 plasma) and increased the sample size, the 
relationship was clear (Pearson’s R =  0.868, p<0.01). There was a direct relationship 
between plasma BC concentration and the BC associated with high density lipoprotein 
(Figure 6). On average, 33% o f the plasma BC was associated with the HDL fraction.
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Figure 6 Plasma vs. HDL beta-carotene. Relationship between plasma beta- 
carotene concentration and the amount o f beta-carotene carried in the high density 
lipoprotein fraction of plasma (n = 148). Pearson’s R= 0.868, p<0.01.
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Corpus luteum beta-carotene 
To determine the effect o f dietary BC on the tissue concentration o f BC, the 
concentration o f BC was determined for each CL collected (Table 4). As shown by 
linear orthogonal contrast, the concentration o f BC in the CL was directly related to the 
amount of dietary BC received by the cow in the preceding seven week block 
(p<0.001) (Figure 7). Further, this effect was mediated by the changes in plasma BC 
concentrations, as evidenced by the direct linear relationship between the concentration 
of BC in the plasma and the concentration of BC in the CL of cows from both the 
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Figure 7 Corpus luteum beta-carotene. Corpus luteum beta-carotene 
concentration (nmol/g) grouped by supplemental dietary beta-carotene (mg/day) 
received in the preceding seven weeks. Values are least squares means ± SEM, n = 4 
for each treatment, except 16 and 80 mg/day where n =  3. There was a significant 
linear response to the level o f supplemental dietary beta-carotene (p <0.001).
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Figure 8 Plasma vs. corpus luteum beta-carotene. Relationship between 
plasma beta-carotene concentration (pmol/l) on day o f CL harvest and corpus luteum 
beta-carotene concentration (nmol/g). The relationship (Pearson’s R = 0.903) was 
significant (p <  0.001, n=27).
Subcellular Fractionation
To determine i f  the change in CL beta-carotene concentration was due to 
changes in BC within lipid droplets or within organelles, subcellular fractionation was 
performed. A portion of each of the eighteen corpora lutea collected during the 
supplementation experiment were fractionated, as described, to obtain crude 
mitochondrial, nuclear, microsomal, and lipid fractions. The amount of BC in each 
fraction was determined and expressed relative to the amount of protein in that fraction.
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Graphical depictions of the results are below (Figures 9a-9d). Changes in total CL 
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Figure 9a Mitochondrial fraction beta-carotene. Corpus luteum 
mitochondrial beta-carotene concentration (nmol/g fraction protein) grouped by 
supplemental dietary beta-carotene (mg/day) received in the preceding seven weeks. 
Values are least squares means ±  SEM, n =  4 for each treatment, except 16 and 80 
mg/day where n =  3. There was a significant linear response to the level o f 
supplemental dietary beta-carotene (p <0.01).
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Figure 9b Nuclear fraction beta-carotene. Corpus luteum nuclear beta- 
carotene concentration (nmol/g fraction protein) grouped by supplemental dietary beta- 
carotene (mg/day) received in the preceding seven weeks. Values are least squares 
means ±  SEM, n =  4 for each treatment, except 16 and 80 mg/day where n =  3. 
There was a significant linear response to the level o f supplemental dietary beta- 
carotene (p<0.01).
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Figure 9c Microsomal fraction beta-carotene. Corpus luteum microsomal 
beta-carotene concentration (nmol/g fraction protein) grouped by supplemental dietary 
beta-carotene (mg/day) received in the preceding seven weeks. Values are least 
squares means ±  SEM, n = 4 for each treatment, except 16 and 80 mg/day where n 
= 3. There was a significant linear response to the level o f supplemental dietary beta- 
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Figure 9d Lipid fraction beta-carotene. Corpus luteum lipid fraction beta- 
carotene concentration (nmol/g fraction protein) grouped by supplemental dietary 
beta-carotene (mg/day) received in the preceding seven weeks. Values are least 
squares means ± SEM. n = 4 for each treatment, except 16 and 80 mg/day where n 
= 3. There was a significant linear response to the level o f supplemental dietary beta- 
carotene (p < 0.01).
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Western Immunoblots 
While it has been reported that BC reduces the cross-linking o f Adx and 
P450scc in luteal cells in culture, the effect o f BC on cross-linking in vivo has not been 
studied. To assess the effect o f CL beta-carotene concentration on the cross-linking of 
Adx and P450scc. im mu nob lotting was performed on the separated proteins from all 
corpora lutea collected during the supplementation experiment. Polyclonal antibodies 
were made to bovine adrenodoxin isolated from frozen cow adrenals. The isolated 
protein was analyzed by automated amino acid sequence analysis (Figure 10), and the 
first 19 amino acids in the protein isolate (S-S-S-E-D-K-I-T-V-H-F-l-N-R-D-G-E-T-L) 
are the same as for mature adrenodoxin, as determined by Tanaka et al. (98). Based 
on the relative amount o f other amino acids, the purity o f the isolate was estimated to 
be -8 0 % . The antisera was purified by affinity column chromatography, and the 
various eluents were compared for their reactivity with adrenodoxin standard in 
Western immunoblots.
Antisera to adrenodoxin and to cytochrome P450scc, apart from recognizing 
their respective proteins, also recognized a protein o f higher relative molecular mass 
(Mr) (~63kDa) in their respective immunoblots (Figures 11a and l ib ) .  The M r o f 
this protein was equal to the combined Mr of Adx ( - 1 4  kDa) and P450scc (49 kDa) 
and corresponds to the cross-linked Adx-P450scc protein seen by other researchers 
(84). The figures show the corresponding CL beta-carotene concentrations for each 
lane of the Western blots. Based on visual observations, the cross-linked protein 
appears consistently in the lanes where CL beta-carotene concentrations were below 
-  11 nmol/g. On the other hand, the cross-linked protein is not apparent in lanes
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where the CL beta-carotene concentrations were above ~50 nmol/g. In lanes where 
the CL beta-carotene concentrations are between 11 and 50 nmol/g, the cross-linked 
protein is sometimes apparent, but not consistently.
Control immunoblots were performed to verify the specificity o f the antibodies 
used (Figure 11c). The adrenodoxin antibody reacts with the purified Adx standard, 
but not with lysozyme, a protein o f similar molecular weight. Additionally, CL 
homogenates failed to exhibit any reactive protein bands when incubated with serum 
from the rabbits obtained prior to immunization as the primary antibody, showing that 
the antibody to the reactive protein is produced only after immunization with Adx. 
Also, no reactive proteins were identified when blots were not incubated with a primary 
antibody, but only the secondary antibody, showing that there was negligible non­
specific binding o f the enzyme-labeled secondary antibody.
Other researchers have observed the cross-linking of Adx and P450scc when 
luteal cells are grown in culture without supplementation of BC (84). Therefore, as a 
positive control, homogenates of luteal cells cultured for 48 hours without 
supplementary BC were analyzed by Western immunoblotting for the presence of the 
cross-linked protein. All cell homogenates (n =  14) contained the cross-linked protein 
(immunoblots not shown).
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Amino Acid Scr Scr Ser Giu Asp Lys lie Thr Val His Phc lie Asn Arf> Asp Glv Glu Thr Leu
Abbrcv S S S E D K I T V H F I N R D G E T L
Cycle 1 231.2 30.8 26.5 18.7 16 5 11.3 18.7 0 0 29.6 22.6 0.0 21.5 313
Cycle 2 139.0 4 7 6 48.8 17.3 11.0 9.0 36 9 0 0 6 8 17.8 0.0 21.9 19.1
Cycle 3 118.4 58.4 53.1 14.1 14.6 11.5 18.8 0 0 4.5 6.2 31.8 17.8 19.7
Cycle 4 34.4 133.0 53.5 69.3 13.9 14.9 12.2 0.0 39.4 5.5 8.7 16 7 17 2
Cycle 5 21.6 48.3 162.8 50.2 28.8 15.0 9.9 3 3 32.1 5.4 5.0 24.2 17.9
Cycle 6 13.2 31.4 65.1 159.7 20.3 37.8 9.2 0.0 16.6 5.5 4.1 25.3 22.1
Cycle 7 14.7 35.4 40.0 66 5 102.6 34.7 21.1 0 0 28.8 6 1 3.2 24.0 20.5
Cycle 8 14.2 31.7 33.1 58.0 36.0 94.1 20.3 10 5 17 1 6.2 4.2 22.6 26.8
Cycle 9 13.6 31.2 38.6 45.4 24.4 36.3 93.7 25 2 19.3 6.0 4.5 270 204
Cycle 10 17 3 32.5 37.3; 32.9 23.4 27.6 38.6 76.1 16.1 6.3 4.9 27.7 18.7
Cycle 11 16.9 31.7 31.61 32.0 28.6 19.9 26.6 29 8 74.6 12.5 6.3 23.9 24.2
Cycle 12 1 5 0 30.2 27.0 35.4 18.5 26 9 16 2 32.0 74.8 13.8 10.2 22.0 23.8
Cycle 13 6.7 23.8 39.3: 29.6 23.2 20.0 7.9 16.9 35.8 51.7 14.5; 22.7 24 9
Cycle 14 12 1 19.5 37.4: 26.0 23.0 21.0 6 1 11.9 23.2 24.2 58.1 22.8 23 6
Cycle 15 14 5 21.6 24.7 17.0 23.2 6.5 9.3 18.0 14.1 30.3 64.6 21.3 24 2
Cycle 16 15.5 21.1 23.4 17.2 20.5 4 6 8.3 17.1 1 3.2 21.1 45.1 47.4 264
Cycle 17 13 6 22.0 18.7 18 6 5 4 9.1 14.7 9.6 8.7 36.0 319 33.2 26.3
Cycle 18 12 9 20.6 22.1 4 8 7.4 13.8 8.3 6.7 32 6 23.7 21.4 39.7 25 3
Cycle 19 6.5 21.3 19.7 6 8 7.6 14.3 10.1 6.8 29.3 21.4 16 I 27.7 46.0
in
CD
Figure 10 Amino acid sequence of isolated protein. The amino acid sequence (first 19 amino acids) o f the isolated 
protein was determined. This table shows the amount o f each amino acid detected during sequencing in picomoles. The bold and 
shaded numbers are the predominant amino acid detected for that cycle. The amino acids (columns) are arranged to show the 
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Corpus Lnleiim Beta-caroteoe Concentration (nmol/g)
F jgm tllm  Western immunoblots o f corpus luteum tissue from  cows receiving various 
levels o f dietary beta-carotene, developed w ith  antibody to adrenodoxin. In  addition to 
the adrenodoxin band, at -14 kiloDaltons (kDa), a second protein, at -63 kDa, was 
detected by the antibody in  some lanes. Corpus luteum beta-carotene concentration fo r 
each respective lane is shown.
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Corpus Luteum Beta-carotene Concentration (nmol/g)
Fjgure lib  Western immunoblots o f corpus luteum tissue from  cows receiving various 
levels o f dietaiy beta-caiotene, developed w ith  antibody to cytochrome P-450scc. In 
addition to the P-450scc band, at ~49 kiloDaltons (kDa), a second protein, at ~63 kDa, 
was detected by the antibody in  some lanes. Corpus luteum beta-carotene concentration 







Adz Sid Lysozyme Prwmmime No Primary
Soram Antibody
Fjgum  11c Representative lanes from control vestem immunoblots. Lane 1 is the purified Adx standard 
developed in the same manner as the corpus luteum homogenates. Lane 2 is the purified protein lysozyme, 
developed in the same manner as the corpus luteum homogenates. Lane 3 is corpus luteum homogenate 
developed vith pie-immune serum as the primary antibody. Lane 4 is corpus luteum homogenate developed vith 
no primary antibody No protein bands are observed vhen specific antibody is not used as the primary antibody 
and the Adx antibody does not recognize lysozyme, a protein of similar molecular veight (~ 14.3 kDa).
Plasma Progesterone 
Cross-linking of Adx and P450scc, two enzymes involved in progesterone 
synthesis within the CL, may be expected to affect plasma progesterone (P4) 
concentrations. Therefore, plasma and corpus luteum P4 concentrations were 
determined for each cow on the day of CL harvest in an attempt to determine i f  the 
changes in dietary BC had any effect on CL function. There were no significant 
differences in plasma or CL progesterone concentration between treatment groups 
(Figure 12a and 12b). Nor was there any difference in total CL progesterone content 
between treatment groups (Figure 12c).
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Figure 12a. Plasma progesterone. Plasma progesterone concentration (ng/ml) 
on day of corpus luteum harvest grouped by supplemental dietary beta-carotene 
(mg/day) received in the preceding seven weeks. Values are least squares means ± 
SEM, n = 4 for each treatment, except 16 and 80 mg/day where n =  3. There was 
no statistically significant difference between treatment groups.
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Figure 12b Corpus luteum progesterone concentration. Corpus luteum progesterone 
concentration (pg/g) on day of corpus luteum harvest grouped by supplemental dietary 
beta-carotene (mg/day) received in the preceding seven weeks. Values are least squares 
means ± SEM, n = 4 for each treatment, except 16 and 80 mg/day where n =  3.
There was no statistically significant difference between treatment groups.
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Figure 12c Corpus luteum progesterone content. Corpus luteum progesterone 
content (pg) on day o f corpus luteum harvest grouped by supplemental dietary beta- 
carotene (mg/day) received in the preceding seven weeks. Values are least squares 
means ± SEM, n =  4 for each treatment, except 16 and 80 mg/day where n = 3. 
There was no statistically significant difference between treatment groups.
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Alpha-tocopherol
Plasma and CL alpha-tocopherol (AT) concentrations were determined. There 
was not a significant difference in either plasma AT concentration (Figure 13a) or in 
CL alpha-tocopherol concentration (Figure 13b) between cows receiving different 
levels o f dietary BC. Additionally, the AT to BC ratio in the CL was directly related 
to the ratio in plasma (Figure 13c), suggesting that there was not preferential uptake of 
either.
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Figure I3a  Plasma alpha-tocopherol. Plasma alpha-tocopherol concentration 
(fimol/1) on day of corpus luteum harvest grouped by supplemental dietary beta- 
carotene (mg/day) received in the preceding seven weeks. Values are least squares 
means ± SEM, n =  4 for each treatment. There was no statistically significant 
difference between treatment groups.
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Figure 13b Corpus luteum alpha-tocopherol. Corpus luteum alpha- 
tocopherol concentration (pmol/l) on day of corpus luteum harvest grouped by 
supplemental dietary beta-carotene (mg/day) received in the preceding seven 
weeks. Values are least squares means ± SEM, n =  4 for each treatment, except 
16 and 80 mg/day where n = 3. There was no statistically significant 
difference between treatment groups.
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Figure 13c Plasma vs. corpus luteum alpha-tocopherol to beta-carotene 
ratio. Relationship between plasma alpha-tocopherol to beta-carotene ratio on day o f 
CL harvest and corpus luteum alpha-tocopherol to beta-carotene ratio. The linear 
relationship (Pearson’s R = 0.756) was significant (p < 0.001, n = 18).
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Histology and Cell Ultrastructure 
In order to assess the effects o f BC on the organization o f the CL and on the 
ultrastructure o f its cells, tissue sections for light microscope and transmission electron 
microscope (TEM) examination were prepared. Light microscopy at 25 and lOOx 
magnification revealed no obvious differences in tissue organization between treatments 
(Figures 14 and 15). The CL contained cells o f varying sizes, representing small and 
large luteal cells and non-steroidogenic cells in an extensive extracellular matrix. The 
luteal cells possessed a uniform granular cytoplasm with many vacuoles which were 
shown to be lipid filled by TEM. Electron micrographs, taken at 5000 and 10000 x 
magnification, o f tissue sections from corpora lutea from blocks 1 and 2 were examined 
to determine i f  there were differences in mitochondria appearance between 
treatments(Figure 16). No apparent differences were seen. Luteal cells contained 
numerous mitochondria and the mitochondria appeared morphologically normal (i.e., 
intact double membrane and tubular cristae were visible, no gigantism or swelling 
observed, and no abnormal inclusions). The luteal cells also exhibited a great deal of 
smooth endoplasmic reticulum and numerous membrane-bound lipid droplets, two 
additional hallmarks of steroidogenic cells.
76
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 14 Hematoxylin and eosin-stained sections. Pictured, are representative 
photographs of corpus luteum sections which were stained with hematoxylin and eosin 
(photographed at 25 (A) and 100 (B) x magnification). Note the heterogeneous cell 
size, extensive vascularization, and uniform granular cytoplasm. Symbols: LL = large 
luteal cell, SL =  small luteal cell. Small arrow = stromal cell, and large arrow = 
capillary with red blood cells.
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Figure 15 Masson’s trichrome-stained sections. Pictured, are representative 
photographs o f corpus luteum sections which were stained with Masson’s trichrome 
(photographed at 25 (A) and 100 (B) x magnification). Note the heterogeneous cell 
size, extensive vascularization, and uniform granular cytoplasm. Symbols: LL = large 
luteal cell. SL =  small luteal cell. Small arrow =  stromal cell, and large arrow = 
capillary with red blood cells.
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Figure 16 Electron micrographs. Pictured, are representative micrographs o f corpus 
luteum sections (magnification o f photograph: A =  9,000 x ; B = 18,000 x). Note the 
numerous lipid droplets (L), mitochondria (M), and smooth endoplasmic reticulum 
(arrowhead) characteristic o f steroidogenic tissue.
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CHAPTER IV
DISCUSSION
Numerous epidemiological studies have shown an inverse relationship between 
the consumption o f fruit and vegetables rich in beta-carotene (BC) and the incidence of 
chronic diseases such as cardiovascular disease, some cancers, and age-related macular 
degeneration (27). However, double-blind intervention trials which expose subjects to 
BC supplements have failed to show consistent benefit. Indeed, two studies suggest a 
negative effect o f supplemental BC on cancer incidence in high-risk populations 
(29,99). The hypothesis that BC is the protective component in fruits and vegetables, 
was formed based largely on in vitro experiments and observational data (6 ). To date, 
no definitive in vivo function of BC has been shown, other than its role as a vitamin A 
precursor.
Likewise, in the cow there have been conflicting reports regarding the positive 
impact of BC on fertility. These reports have been based on both observational data 
and dietary supplementation trials. Hemken and Bremel (79) reported on several 
studies in Germany which showed an increased length o f estrous period and a decreased 
conception rate in cows fed a low BC ration compared to a supplemented group (0.3 
mg / kg body weight). They also found that corpus luteum progesterone concentration 
was lower in unsupplemented cows. Graves et al. (80) found that plasma progesterone
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was positively correlated with plasma BC concentrations in a 39 cow study and Jackson
(82) saw an inverse correlation between plasma BC and number o f services to 
conception. On the other hand, Ascarelli et al. (81) saw no effect o f supplemental BC 
(>  500 mg/day) on reproductive parameters.
One problem with interpreting the results o f intervention trials in both humans 
and cows is the basal BC status o f the population. I f  an individual already has adequate 
BC, then no effect of supplemental BC would be expected. Folman et al. (83) reviewed 
the case for beta-carotene’s enhancement o f fertility in cows and found that, in some 
experiments where the basal BC levels were below 0.931 pmol/1, BC supplementation 
increased fertility. However, there was no case in which fertility was affected when 
plasma BC exceeded 2.794 umol/l. Therefore, using control groups which have 
sufficiently low BC status may be crucial to discerning an effect o f supplemental BC.
In an attempt to resolve some of the conflicting results in the literature, it is 
necessary to investigate the function o f BC in vivo to determine the mechanism which 
would explain the observed associations. While most measures o f BC status are based 
on plasma concentrations, i f  BC is affecting fertility or the incidence of disease, it is 
most likely that these outcomes are being mediated in the tissues at the cellular level. 
Therefore, determining the relationship between plasma and tissue BC concentrations is 
an important step in the interpretation of plasma BC data collected from a large 
population.
Collecting tissue from humans is problematic. What little information is 
available on BC in human tissues is based on needle biopsies or biopsy samples at time 
of surgery for some other cause (89), non-invasive techniques such as cell scrapings
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(100), or indirect techniques such as light remittance o f skin (34). Therefore, an 
animal model which absorbs and accumulates intact BC is necessary. The cow may be 
one such model, because o f its high plasma and tissue concentrations o f BC. The 
possible associations between BC and fertility in dairy cows provides an added 
incentive to investigate BC metabolism in this animal.
The studies presented in this dissertation were designed to elucidate the 
relationship between plasma and tissue BC in the cow, determine the subcellular 
distribution o f BC within the bovine corpus luteum, and assess the impact o f dietary BC 
on the steroidogenic function of the CL. For the sake o f clarity, when referring to the 
final study in which dietary BC intake was manipulated, the acronym DAISS (Dietary 
Alteration’s Impact on Steroidogenesis Study) w ill be used. The purpose o f these 
studies was two-fold: to determine the suitability o f the bovine CL to serve as a model 
o f tissue BC metabolism and to identify a function o f BC which might explain its 
reported effect on fertility in dairy cows. Because o f its high concentration o f BC, the 
CL may be the site o f beta-carotene’s influence on fertility.
As in humans (34, 35), there is variability in the plasma concentration o f BC 
among cows being fed the same diet. In preliminary experiments, the variability within 
and between cows was determined for various measures (Table 3). The intercow 
variability of plasma BC o f 26.5% is in good agreement with that of Hoppe et al. (47). 
They found an intercalf variability of -30%  for plasma BC and an intracaif variation 
o f -7 % . This compares to the preliminary studies’ intracow variability o f 12.9%. 
However, the intracalf variability determined by Hoppe was based on seven
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measurements at four hour intervals, while this study compared 3-4 measurements over 
a six month period.
Because o f the difficulty associated with obtaining successive tissue samples 
from one individual, little information is available regarding the intraindividual 
variability o f BC concentration of tissues. The CL is easily accessible and corpora 
lutea can be obtained repeatedly from the same cow, thus making it available for study. 
Preliminary experiments demonstrated that the inter- and intracow variability in CL 
beta-carotene concentration were 36.3% and 18.3%, respectively (Table 3). This 
variability is slightly greater than the 26.5% and 12.9% seen in plasma values.
The variability in plasma and tissue BC. both within and between cows, needs 
to be considered when designing experiments. When only single measures are taken on 
individuals, any variation in response due to interindividual variation becomes pan of 
the error sum o f squares. As a result, it is more difficult to obtain statistically 
significant results, and the number o f subjects may need to be increased. By contrast, 
studies which take repeated measures on the same individual allow the partitioning of 
the sums o f squares into both within and between cow variability. Repeated measures 
are practical in the cow for both plasma and CL parameters, because of the ease of 
blood sampling and the ability to obtain successive corpora lutea, thus reducing the 
needed sample size, and increasing statistical power. Therefore, experimental designs 
which utilize repeated-measures and the crossover from one treatment to another may 
be particularly valuable in reducing the confounding effect o f interindividual 
variability.
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Dairy cows, in areas where forage is plentiful, are usually fed rations which 
contain feeds like com silage, hay, and/or haylage. These forages contain high BC 
concentrations and contribute to the high BC concentration found in cows’ plasma and 
tissue (73). When consuming a typical ration, cows in preliminary studies (Table 3) 
had mean plasma BC concentrations o f 9.891 pmol/l (Standard deviation (SD)= 2.717; 
Range= 6.413-17.090) and mean corpus luteum concentrations o f 139.053 nmol/g 
(SD= 52.236; Range =  70.541-248.399). According to Folman (83), there are no 
studies which reported a beneficial effect o f supplemental BC when cows had plasma 
BC concentrations greater than 2.8 pmol/l. Plasma concentrations this low are only 
seen in cows which are receiving minimal amounts o f forage, or poor quality forages 
such as straw. This occurs in regions of the world where arable land is scarce and 
dedicated mainly to the production of foods for human consumption, such as occurs in 
Israel (81). In these regions, cows are fed grains and feed by-products which provide 
the bulk of energy in the ration, and given forage in quantities sufficient to maintain 
rumen function. In the United States, in contrast, forages make up the bulk of the 
ration, with concentrates being fed to increase energy density o f the ration and ensure 
adequate caloric intake in high-producing dairy cows.
To achieve low plasma and corpus luteum BC concentrations in the cows in the 
DAISS, a ration composed largely of straw was formulated to meet the nutritional 
requirements o f the cows. Straw, the stalks and leaves o f grain plants (in this case, 
wheat), is allowed to dry in the field and is then baled for transport to the farm. 
Because the grain from these plants is harvested after it ripens and dries, these plants 
have been dead for several weeks prior to harvest. This, combined with the field-
84
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
curing, result in a low BC content in straw. The remainder of the ration consisted o f a 
small amount o f com silage (to enhance palatability), soy bean meal (to increase ration 
protein content), com meal (to increase energy density), and Sunshine Plus Pellets (to 
provide energy, protein and vitamin E). The ration was top-dressed with a molasses- 
coated grain, which is very palatable and provided a vehicle to incorporate 
supplemental BC. When fed the basal ration with no supplemental BC for seven 
weeks, cows in the DAISS had mean plasma BC concentrations of 1.403 p.mol/1 (SD =
0.602, Range= 0.916-2.279) (Table 4). These concentrations fall within the range in 
which previous studies have shown a beneficial effect o f supplemental BC on fertility
(83). Feeding o f this ration also resulted in a decrease in the mean corpus luteum BC 
concentrations in these cows to 18.827 nmol/g (SD= 11.504, Range= 4.672-32.901) 
(Table 4). This represents a substantial decrease from the tissue/blood concentrations 
seen when cows are fed a typical dairy ration.
The plasma BC concentrations achieved in cows receiving no supplemental BC 
or the lowest BC supplementation levels are approaching the range o f the human 
population aged four years and older (0.09-0.91 pmol/1, 5th-95th percentiles) 
(Unpublished NHANES III data, NCHS, 1996. Presented at EB '96, Washington, DC 
4/17/96). Nierenberg et al. (39) found that in humans supplemented with 30 mg/day 
BC for one year, mean plasma BC concentration was 3.163 pmol/l. In DAISS. all 
cows, except those receiving 80 mg/day BC, had plasma BC concentrations less than 
2.6 pmol/l (Table 4). Additionally, the corpus luteum BC concentrations of 
unsupplemented cows ranged from 4.672 to 32.901 nmol/g. Yokoe and Takenaka (77) 
reported human CL concentrations of BC ranging from ~2.0 to 93.1 nmol/g. Thus.
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by manipulating dietary BC intake in the cow, CL and plasma BC concentrations 
comparable to those seen in humans can be achieved. This is critical i f  the bovine CL 
is to be developed as a model for BC metabolism and inferences are to be drawn 
regarding the function of BC in humans.
There was a direct linear relationship between the amount o f supplemental BC 
fed and the CL and plasma BC concentrations measured in DAISS (Figure 8). This 
relationship gives future researchers the ability to control and predict the BC content of 
the CL based on dietary intake. This w ill be useful in studies examining the effects o f 
different cellular BC concentrations on function within the CL, because desired cellular 
BC concentrations can be predictably achieved.
The change in cellular BC concentration is also reflected in the subcellular 
organelles (Figures 9a-9d). The CL contains lipid droplets which provide the stores of 
cholesterol needed as a substrate for steroid synthesis. The DAISS shows that the 
change in corpus luteum BC concentration is not due solely to changes in the BC 
content o f these lipid droplets. This is significant, because presumably BC can only 
function within the cell i f  it is located at critical sites. Beta-carotene associated with the 
lipid droplets might protect the lipid from peroxidation, but would be unable to 
scavenge free radicals at other sites within the cell. Nuclear, mitochondrial, and 
microsomal fractions had increased BC concentrations which paralleled the increase in 
CL beta-carotene in those cows receiving supplemental BC. Therefore, BC would be 
in a location to scavenge free-radicals formed in these organelles.
The reported association between BC and fertility in dairy cows, while 
inconsistent, suggests a function for BC. Since the CL is a site o f BC accumulation
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and the primary function of the CL is the production and secretion o f progesterone, it 
seemed likely that BC would have some relationship with the steroidogenic capacity of 
the CL. Adrenodoxin and cytochrome P450scc are two enzymes which catalyze the 
first and rate-limiting reaction in the formation o f steroids from cholesterol. Young et 
al. (84) observed that luteal cells grown in culture exhibited cross-linking between Adx 
and P450scc, except when the culture medium was supplemented with BC.
To determine i f  this effect occurs in vivo, the cross-linking o f Adx and P450scc 
was assessed by Western immunoblotting in the corpora lutea obtained from cows 
during DAISS (Figures I  la  and lib ). The cross-linked protein ( - 6 3  kDa) was found 
in all corpora lutea which had BC concentrations o f 11.035 nmol/g or lower, and was 
seen in some which had BC concentrations below 41.135 nmol/g. No cross-linking 
was observed in corpora lutea which had BC concentrations of 53.017 nmol/g or 
higher. In terms o f plasma BC concentration, no cross-linking was seen in cows when 
their plasma BC concentration was higher than 2.599 pmol/1. This finding is 
interesting when one considers Folman’s (83) interpretation o f the literature that no 
beneficial effect o f supplemental BC is seen in those cows with plasma BC 
concentrations greater than 2.8 pmol/1. This suggests that there is some minimal level 
of BC needed within the CL to prevent the cross-linking, and that increasing the 
concentration beyond that point has no beneficial effect.
In spite o f the cross-linking seen in some o f the corpora lutea, there was no 
effect seen on the plasma progesterone concentration on the day of CL harvest (Figure 
12), nor on the morphology of the mitochondria, nor on the structure of the tissue as 
observed in histological sections (Figures 14-16). Therefore, it is unclear whether
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cross-linking signifies a detrimental condition within the CL or whether it is simply a 
curious observation. However, cross-linking may be a cumulative process, that would 
result in functional or morphological defects after a longer period o f time. The corpora 
lutea obtained during this study were 9-11 days old. In normal cycles, i f  fertilization 
occurs, the CL continues to produce progesterone, and the CL’s functioning beyond the 
150th day is necessary to sustain pregnancy. I f  cross-linking occurs in these corpora 
lutea, it is possible that inadequate quantities o f progesterone would be produced and 
fertility would be affected. Investigation o f this possibility w ill be more difficult, 
because harvesting the CL would result in the termination o f the pregnancy, and 
corpora lutea from pregnant slaughterhouse animals would be from cows with unknown 
dietary BC history.
The CL is a metabolically active tissue and may, therefore, produce large 
quantities o f free radicals. Steroidogenesis has been shown to produce free-radicals in 
vitro (67) and hydrogen peroxide is produced in the rat CL (6 8 ). Cells typically contain 
a host o f enzymatic and non-enzymatic defenses to protect against the damaging effects 
o f free-radicals (101). Beta-carotene is an antioxidant in vitro and functions in plants 
to protect chlorophyll from the damaging effects of free-radicals. Therefore, BC may 
be inhibiting cross-linking by scavenging free-radicals which cause the cross-linking.
The observed cross-linking may have implications for other tissues also. 
Because of its short life-span (18 days or 273 days in non-fertile or fertile cycles, 
respectively) the oxidative damage may be o f limited consequence within the CL. 
However, in other tissues, the lifetime accumulation o f oxidative damage may have 
profound consequences. Free-radical damage has been suggested to mediate the effects
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of aging and the pathogenesis of many chronic diseases such as, cancer, arthritis, and 
cardiovascular disease (102). Beta-carotene may scavenge free-radicals in other tissues 
and affect these conditions.
During DAISS, a second antioxidant, vitamin E, was maintained at normal 
levels. Since vitamin E is also an antioxidant, it is possible that low plasma and CL 
concentrations o f vitamin E might confound any results due to altered BC 
concentrations. The basal ration resulted in a decline in plasma vitamin E 
concentrations until Sunshine Plus Pellets were added, at which time plasma vitamin E 
concentrations returned to the normal range (data not presented). This suggests that in 
cows receiving low forage diets, declines in plasma BC may be paralleled by declines 
in plasma vitamin E. Since both nutrients are antioxidants, their simultaneous decline 
may result in far more oxidative damage. It would be interesting to perform a two- 
factor experiment in which BC and/or vitamin E were supplemented and the effect on 
cross-linking observed.
Clearly, the CL has potential to serve as a model for the study of BC function in 
tissue. DAISS shows that successive corpora lutea can be obtained from the same cow. 
and that the concentration of BC within the CL can be modified by dietary 
manipulation over a short period of time. Because the CL is formed anew each cycle, 
the BC concentrations found in the CL reflect the BC concentrations of the plasma at 
the time it develops. Other tissues that accumulate BC may retain high concentrations 
for an extended time after plasma concentrations decline. This lack of a “ memory'’ of 
past BC exposure, allows rapid manipulation of the tissue BC content in the CL.
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The concentration of BC associated with the nuclear fraction was also altered in 
DA1SS. This may be valuable in research seeking to elucidate a functional mechanism 
to explain the relationship between BC and cancer. Since cancer is a disease associated 
with changes in DNA, the nucleus is the site at which one would expect to see an effect 
o f BC. i f  an effect exists. Using the CL as a model, researchers could manipulate the 
nuclear content o f BC and assess its impact on induced mutagenesis and transformation.
Another area o f research which may benefit from the CL as a model is the area 
o f intracellular trafficking of BC. Beta-carotene is highly hydrophobic, and is therefore 
insoluble in the aqueous environment o f the cell. How BC is transported within the 
cell and incorporated into organelles, is a question which has not been addressed.
The DAISS study presented here demonstrates that, through the manipulation of 
dietary BC. plasma and corpus luteum concentrations within the cow can be altered and 
lowered to concentrations comparable to those seen in humans. Combined with the 
ability to obtain successive corpora lutea from the same cow, this provides researchers 
with a feasible model to study BC accumulation and metabolism. Applying these 
techniques, beta-carotene was shown to inhibit the cross-linking of the steroidogenic 
enzymes adrenodoxin and cytochrome P450scc in vivo. Whether this cross-linking 
may explain the reported association between BC and fertility in dairy cows remains to 
be determined.
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APPENDIX
Serum Carotenoid Reference Ranges 
S ^ S 11 percentiles, age 4 years and older 
Source: CDC/NCHS, NHANES in , 1988-94
CAROTENOID pg/dL pmol/L
Lycopene 7-44 0.13-0.82




Unpublished NHANES III data. NCHS, 1996. 
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